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SUMMARY
Dexamethasone, a glucocorticoid, is used extensively in clinical medicine in the 
treatment of respiratory diseases, notably asthma. This medical effect is probably due in 
part to a down-regulation of many cytokines e.g.. IL-8. However, the side effects of 
steroids often may outweigh the beneficial effects, especially if the disease in question 
is of a chronic nature. This combined with steroid resistance has led to an increase in 
the use of non-steroidal anti-inflammatory drugs. These tend to be aspirin derivatives, 
and many have side-effects. I have investigated a factor that is naturally produced by 
the body which may alleviate the symptoms of inflammation without many of the side- 
effects, with an aim to providing a viable alternative.
A novel steroid induced monocyte derived factor was described twenty years ago by 
Stevenson as part of an MD thesis submitted to this university. Tliis remains an unusual 
phenomenon, as most of the effects of steroids are due to a down-regulation of release; 
here is one of the few examples of the reverse. Although it raised many interesting 
points about dispersive motility of populations of polymorphonuclear leukocytes 
(PMN) it did not look at individual cells, nor at many of the interesting properties of 
neutrophils.
One of the known effects of some steroids (though not Dexamethasone), and many 
NSAIDs, is a reduction of adhesion of PMN to venous endothelium. Human umbilical 
vein endothelial cells (and bovine aorta endothelium) were used as an ex vivo model 
for this, and my results show there is a marked decrease in this adhesion. This effect 
was observed not only on resting endothelium, but also when the endothelial cells had 
been pre-treated with IL ip or thrombin. This decreased adhesion was due to an 
interaction with the PMN and the factor, as shown by adhesion being reduced when 
protein coated coverslips were used as the substrate for adhesion. It is suspected that 
the reasons for tliis may be due to an inactivation of integrins such as Mac-1, although a
XIV
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role for selectins cannot be ruled out. Recent work by Diaz-Gonzalez suggests that 
some NSAIDs act by inducing PMN to shed L-selectin.
Other effects of this steroid induced monocyte derived factor on human PMN were 
determined using biological and biochemical techniques.
Previous work has shown a novel dispersive effect of this factor on PMN when used in 
a uniform concentration, and so I decided to look at the moiphology of treated PMN. 
Using scanning electron microscopy I observed a polarisation of the PMN, but without 
any mffling of the membrane, a feature that is normally observed with polarisation. 
This morphology was not observed with control supernatants taken from monocytes 
cultured in the absence of Dexamethasone. This moiphology was conserved using cells 
in suspension and adhered to bovine aorta endothelium. The underlying actin 
cytoskeleton was examined using confocal microscopy, and the microfilamentous aiTay 
was noted as being devoid of spikes, observed with activation, for example with 
fMLP.
Late cytoskeletal controlled effects, the release of granule contents, were also 
investigated, and it was noted that the release of primary granule contents could be 
inhibited by this factor in a dose dependent manner. This fusion of granules with the 
plasma membrane is controlled by the activation of numerous tyrosine kinases, and 
follows a strict order. Secondary granule release was shown to be inhibited also, as 
assayed by the cleavage of type I collagen, and analysis of SDS gels.
The effects on the metabolic burst showed conflicting results with inhibition being 
present, again in a dose dependent manner, but much of this activity was removed with 
increasing purification, leaving only veiy slight inhibition.
XV
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Introduction
1 . 1 . 1 .  The role of the innate immune response in inflammation
1 . 1 . 2 .  Professional phagocytes
1
Innate immune responses are defined as the protective responses of the body to 
pathogens which do not require immunological memory and can therefore be mounted 
as immediate defence mechanisms (Roitt). In higher animals many of the innate 
response mechanisms depend on the properties of the complement proteins, but the 
major contribution is made by the cells now teimed as professional phagocytes. 
Corticosteroids are recognised as the major physiological modulators of neutrophil 
function. The work in this thesis stems from the fact that steroid treated monocytes 
secrete a factor that modulates neutrophil behaviour (Stevenson, 1974, Chettibi et ah, 
1993). The aims were to characterise the factor in terms of the known properties of 
neutrophils
Granulocytic cells of the myeloid lineage are recognised as being major effectors of the 
innate immune response. They have been traditionally classified in terms of 
histochemical properties as neutrophils, eosinophils and basophils (Muiphy). Of these, 
neutrophils are both the most abundant and the most active phagocytic cells (Roitt).
Mammalian neutrophils, eosinophils and basophils have a highly characteristic 
morphology in that the largely inactive nucleus is multilobed and this has led to the 
widespread use of the nomenclature polymoiphonuclear leukocyte abbreviated to PMN.
The granules whieh characterised neutrophils eosinophils and basophils are responsible 
for the histochemical properties of these cells and therefore differ markedly between the 
cell types. The cell types are also characterised by surface antigens using the CD 
nomenclature with CD 14 being characteristic of human PMNs.
At any one time the average adult human has around 10^  ^ PMNs with a half life in 
circulation of approximately 8 hours (Abbas). PMNs develop from pluripotent stems
■i.:
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Introduction
ceils by pre-programmed cell division within the bone marrow and continue to 
differentiate over a period of 5-7 days, figure 1. Commitment to each stage of this 
developmental pathway, which is irreversible, is regulated by a variety of signalling 
peptides. The biosynthetic activity involved in maintaining the PMN population is 
calculated to be almost as great as that involved in maintaining the far more abundant 
erythrocyte population.
The second class of professional phagocytes are monocyte derived, consisting of 
circulating mononuclear cells (monocytes) which are weakly phagocytic and leave the 
blood stream after a short residence period, to become highly phagocytic tissue 
macrophages. Macrophages are antigen presenting cells of crucial importance to the 
acquired immune response (Abbas). Both monocytes and macrophages are active 
producers of cytokines which regulate the activities of neutrophils, among other cells. 
In principle, macrophages should regulate local activities, whilst monocytes could act 
as global regulators. The best characterised signalling functions of these cells is the 
release of proinflammatory cytokines which up-regulate neutrophil activity (Roitt). 
However they are also known to be the primary targets for glucocorticoids 
(corticosteroids). Because glucocorticoids are among the most powerful known anti- 
inflammatoiy agents they are believed to be the major physiological down regulators of 
the innate immune response. Within the circulation they are ideally placed to function as 
global regulators and to this end the monocytes (and endothelial cells) could be seen as 
the primary targets.
Finally it should be noted that the enormous task of clearing senescent neutrophils from 
the blood stream is probably carried out by macrophages, although the details of this 
are obscure.
. .I
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Fig 1. Haematopoesis. Differentiation of granulocytes
sismcefl 5 sen» cell
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Different cytokines produce the different granulocytes in an irreversible process 
whereby once a cell fate is determined it cannot be changed. CD antigens present on the 
cell surface are indicated within the body of the cells. Not to scale. (After Roitt).
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1 .2 . Neutrophil activation in inflammation
1 .2 .1 .  Adhesion
Neutrophils in the bloodstream are divided into the non-marginating and marginating 
pools; the former being in free suspension in the plasma and the latter being more or 
less tightly associated with blood vessel walls. Thomas Wharton-Jones (1842) made 
the initial observations which suggested that leukocytes roll along the endothelium of 
veins, but the reasons for this remained confused for some time (including that specific 
gravity was forcing the heavier cells to the outside (Ki'ogh)). More recently it has been 
postulated that there is a basal level of rolling of PMNs, but that adhesion is only
I- ': '
triggered by specific mechanisms (Lorant et ah, 1995; Kubes, 1993).
Signals for the innate immune response include, the recognition of non-self (non­
protected) surfaces by complement components, specific bacterial toxins, especially 
LPS and by chemotactic factors. These signals are recognised by mononuclear cells and 
endothelial cells which respond by sending out secondary signals, e.g. histamine, IL- 
1(3, TNFoc (Roitt). The abluminal surface of the endothelium has receptors for such 
molecules and responds by releasing Weibel-Palade bodies from the cytoplasm to the 
luminal surface. These bodies contain integral membrane proteins that are required for 
the adhesion of leukocytes, especially E-selectin - a ligand for the neutrophil adhesion 
receptor L-selectin, and also a quantity of P-selectin, which also has role in 
inflammation (Lorant et ah, 1993).
s
It is now known that adhesion of neutrophils to the endothelium has two distinct 
components mediated by selectins and integrins (Bevilaqua, 1993; Pardi et ah, 1992).
Selectins are carbohydrate binding proteins on the external surface of the plasma 
membrane which are analogous to plant lectins. They have high specificity for sialyl 
residues and they themselves are sialyl glycoproteins. Their proposed role is to retard 
the PMNs as an essential preliminary to stronger adhesion. Neutrophils constitutively
?
■
:______________________________________  Introduction
express L-selectin on the cell surface, and ligands for this (including E-selectin) are
released to the PM of the endothelial cells; i.e. there is selectin mediated adhesion on 
both surfaces. The implied hypothesis is that selectin based rolling adhesion forms the 
basis for margination, but in the absence of an inflammatory signal this remains :
reversible. Upregulation of ligands for L-selectin causes PMNs to be retarded 
sufficiently to enable strong binding to occur between |32 integrins on the PMN 
(Spertini et al., 1991), (especially Mac-1), with ICAMs in the endothelial PM (Smith et 
ah, 1988). This control mechanism, whereby the endothelium only releases the ligands 
in response to injury or insult, prevents activated PMN from adhering non-specifically 
to non-activated endothelium. A second control step is initiated when the L-selectin is 
shed from PMNs on activation (Gearing & Newman, 1993). Thus PMN that become 
detached cannot readily adhere to other areas of resting or activated endothelium.
Soluble L-selectin may be capable of adhering to E-selectin bound to endothelial cells, 
and so prevent neutrophil adhesion to anywhere other than localised areas of 
endothelium downstream from the site of adhesion (Gearing & Newman, 1993). % si
1 . 2 . 2 .  Extravasation / diapedesis
:Resting endothelium forms a tight permeability barrier to blood cells and to serum 
proteins >40 kD. Activation of endothelium by IL-l(3/TNFa permits gap formation
%
between cells in response to PMN adhering to them (Kaplanski et al., 1994)), and 
depends on the translocation of cytosolic endothelial vesicles containing E-selectin 
(Weibel-Palade bodies) to the PM (Asako et al., 1992). Integrin based adhesion of 
PMNs to the endothelium is a precondition for the migration of the PMN across the 
endothelial junction into the tissue, a process normally called diapedesis. The evidence 
suggests that interaction of integrin with its cellular ligand activates locomotion which 
enables the PMN to find a gap between cells of the endothelial sheet.
%
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1 .2 .3 .  Migration / chemotaxis
When the PMN reaches its final destination, defined by direct contact with the 
pathogen, phagocytosis is initiated and the organism is destroyed within the 
phagolysosome by a battery of mechanisms. Most attention has been focused on the 
generation of active oxygen species which requires the assembly of the phagosome 
NADPH oxidase (PHOX) and the activation of the hexose monophosphate shunt,
Diapedesis leads to PMN migration through the basement membrane into other tissues. 
This process has been studied in vitro using endothelial cell sheets and in vivo using the 
rabbit ear models. PMN deform during passage between endothelial cells, and this has
been attributed to rearrangement of the actin cytoskeleton. Downey and colleagues
(1991) observed reduction of actin cross linking whilst the cells were passing through 
the endothelium and basement membrane. They proposed that phosphorylation of actin 
by PKA reduced its ability to polymerise, and also that prostaglandins released by the 
endothelial cells could limit cell stiffening, thus allowing PMNs to deform and facilitate 
emigration. The granules within PMNs contain nascent receptors for ECM components 
e.g. laminin, fibronectin, and also degradative enzymes such as collagenase and 
eiastase which may be used for migration pui-poses (Borregaard et ai., 1993). These 
proteases which are specific for connective tissue together with the non-specific 
cathepsins are known to damage to the extra-cellular matrix, although this is believed to 
be reversible. It would be of interest to study the effects of e.g. eiastase gene knock­
out, but at this time there are no such mutants. PMNs are capable of migrating through 
relatively loose collagen gels without necessarily degrading them (Crockett, K.V., PhD 
thesis, 1987). Directional migration to the injury site is brought about by concentration 
gradients of chemotactic agents such as IL-1, IL-8, derived from macrophages,
complement component C5b or formylated peptides etc. derived from pathogens.
' ■11 .2 .4 .  Phagocytosis
Introduction
1 .3 . Neutrophil granules
which provides the energy supply for this system. The activity of PHOX is controlled 
by its regulatory subunits (Segal & Abo, 1993). The membrane components of the 
oxidase are found in more than one class of granule, all of which fuse with the 
phagolysosome during the killing process. Concomitant with membrane fusion is the 
release of soluble peptides (e.g. defensins) and enzymes into the phagolysosome, many 
of which are maintained in an inactive form due to a low pH which is maintained within 
the granules (Ganz & Lehrer, 1994). The activation of the oxidase and osmotic flux 
both aid the increase of the pH and so enzymes such as lysozyme can attack the bacteria 
(Segal & Abo, 1993).
I
The secretory granules which are abundant components of the cytosol of PMNs have 
very important roles in function. It is now recognised that four major classes of granule 
can be described, based on the contents and the order of release of contents. All granule 
types appear to be released by elevation of cytosolic calcium and granules can therefore 
be ordered in terms of the concentration of calcium (or the increase in calcium 
concentration) required to release their specific contents (Sengelpv et ah, 1993). 
Granule secretion is proposed to serve two purposes, the translocation of membrane
It is of interest here to outline the role of these phenomena in determining the four 
classic signs of inflammation turgor (swelling), rubor (redness), calor (increase in body 
temperature) and dolor (pain). Rubor is due to increased blood supply ultimately 
controlled by the arterioles of the capillary bed. Turgor would be a consequence of gap 
formation in the endothelial sheet together with increased capillary pressure. [One of the 
important consequences of enhanced permeability of the capillary wall should be to 
increase the local concentration of complement components in the tissue.] Calor is 
mediated by actions of the pro-inflammatoiy cytokines IL-8 and TNFa and dolor is due 
to the activation of bradykiiiin, synergised by prostaglandins.
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proteins to the cell surface (the PM) and the mobilisation of luminal proteins. Some of 
these may be destined for the extracellular medium, but others may be required to act 
primarily in the phagolysosome. Smaller, less dense, granules would be more efficient
for moving membrane components to the cell surface, whereas larger, denser, granules
would be more appropriate for transporting soluble proteins for release into the
■phagolysosome (Sengelpv et ah, 1993). Phagocytosis produces an increase in cellular 
volume, with osmotic flux accounting for much of the observed swelling (Grinstein et 
ah, 1986).
1 .4 .  Degranulation
PMNs have at least four types of granules, classified as Secretory, Gelatinase, Specific 
and Azurophil in order of release (Sengelpv et ah, 1993). [Previously these had been 
classified as primary, secondary and tertiary, corresponding to azurophil, specific and 
secretory respectively]. Degranulation (the visible disappearance of granules from the 
cell) may involve movement of granules to the surface, but massive degranulation 
probably involves the fusion of granules with each other in addition to fusion with the 
plasma membrane. Degranulation is always associated with the release of components 
into the extracellular medium (Weissmann et ah, 1972). For the early vesicles,
■incorporation of components into the plasma membrane and release of enzymes into the 
extracellular milieu appear to be important for function, but for the later vesicles such 
leakage is now thought to be secondary to the process of phagocytosis.
Secretory vesicles contain many soluble plasma proteins normally found outside the 
cell, but on the membrane itself there are numerous proteins important for later 
activation of the cell, e.g. fMLP receptors. These proteins, by being released (possibly 
nearest the side of the cell exposed to the highest concentration of agonist) may 
contribute significantly to the overall shape change observed in the first few seconds of 
activation, and facilitate chemotaxis (as described in Watts, et ah, 1991). Kaplanski et i
f
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al. (1994) have produced evidence to show that binding of PMNs to an activated 
endothelial cell sheet causes the individual cells to contract and thicken thus generating 
gaps between them. Surprisingly, changes in calcium concentrations do not play a 
major role in the extravasation ability of neutrophils (Zaffran et ak, 1993), although 
endothelial calcium concentrations ([Ca]i) can modulate PMN migration (Huang et al., 
1993). The secretory vesicle membrane contains the major cellulai' pool of the integrin 
Mac-1, primarily responsible for PMN adhesion with the endothelium, hence fusion of 
the secretory vesicle with the PM is a powerful mechanism for regulating adhesion, but 
to be effective it requires to be triggered very rapidly as a result of selectin-mediated 
interactions (Lorant et ak, 1995). The receptors for chemotactic agents are present at 
low level in these vesicles, and are thus upregulated by the events in margination. 
Release of these vesicles to the contact surface could be a mechanism for polarisation. 
CD45, the classic tyrosine phosphatase, is present in high concentrations (relative to the 
other granule types). This may allow activation of many proteins inside the cell, 
especially small GTPases such as Fyn allowing activation of PLCy, PI3K etc., which 
may be important for all subsequent processes (Gaudry et ak, 1992). These vesicles are 
noted as having an unusually low proportion of phosphatidyl ethanolamine, and high in 
phosphatidyl choline in the membrane compared with other granule types (Borregaard 
et ak, 1993). The levels are closer to those observed in the PM (Tauber 1987).
Gelatinase granules were the most recently described, with very few characterised 
contents. Mac-1 and the near ubiquitous fMLP receptor are found on the membrane 
(although at apparently lower levels than with specific granules) with acetyl transferase 
and gelatinase in the lumen (Petrequin et ak, 1987). Gelatinase is defined as being 
types IV and V collagen specific (along with denatured collagen) (Michaelis et ak, 
1992), whilst collagenase, as found in secondary granules, has greater specificity for 
types I, II and III collagen. CD45 is also present on the membrane of these vesicles 
(Lacal et ak, 1988).
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Specific granules have been the most intensively studied of all the PMN granule types. 
Their major membrane components are Mac-1 and cytochrome b558 as well as 
receptors for vitronectin, fibronectin and laminin. These granules have the largest pool 
of fMLP receptors together with receptors for IL-8 and C5b, and are clearly important 
for the late stages of chemotaxis. Receptors for ECM components present on the 
surface of these granules could provide positional information important in signalling. 
Many lytic enzymes are present within the matrix of the granules, such as lysozyme, 
collagenase and enzymes that would be capable of dissolving glysocaminoglycans e.g., 
heparanase, siaiidase. These enzymes could be used to facilitate extravasation through 
the basement membrane and ECM. These granules also contain gelatinase, although it 
appears that the enzyme is complexed with a 25 kD subunit termed NGAL (neutrophil 
gelatinase associated lipocalin) (Kjeldsen et al., 1994), which is exclusive to specific 
granules. NGAL has a low binding affinity with fMLP and could be the low affinity 
receptor of Rossi (1986).
Primary granules store most of the proteolytic and bactericidal enzymes and peptides of 
the cells, but they have no receptors for chemotactic agents or adhesion molecules, and 
this distinguishes them from the other types. It is now understood that these vesicles 
differ from lysosomes in that their internal enzymes are active at neutral rather than 
acidic pH. In the pre-released state, the contents of the primary granule are maintained 
at low pH, and are only activated when the pH rises to neutrality. It is therefore 
essential to prevent tissue damage that these enzymes are contained within the 
phagolysosome and not released into the tissue space.
To a limited degree, different granules are activated by different mechanisms: PMA 
activates specific granules; opsonised zymosan activates 0 2 “ specific granules and 
azurophil granules and formation of phagolysosome; fMLP activates O2" and some 
lysosomal enzymes (Takahashi et ah, 1991). The overall control of degranulation 
requires a co-ordinated series of signals, involving a rise in cytosolic calcium
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concentration (Niessen et ai., 1991) and at least one other signal, possibly involving 
transport of other ions e.g. chloride (Fittschen & Henson, 1994) or perhaps lactic acid 
which has been proposed to buffer the intracellular pH during the release of proteases 
into the phagolysosome (Simchowitz & Textor, 1992). Whatever signals are required 
for the initial stages of the signal transduction pathway leading to degranulation, 
disassembly of microfilaments is almost certainly required (Muallem et al., 1995).
1 . 5 .  Signalling in the neutrophil
Human neutrophils respond to three major types of signalling molecule, the chemokine 
IL-8, chemotactic peptides such as fMLP, and complement components, especially 
C5b. They also respond to lipid derived agents, e.g., LTB4. Signalling triggers shape 
changes (polarisation), enhanced mobility, modification of adhesion, chemotaxis and 
phagocytosis. Despite the diversity of types of molecule, the known receptors for 
chemotactic stimuli are remarkably similar, being of the class of trimeric G-protein 
activating serpentine receptors and then activating the classic phosphatidyl inositol 
bisphosphate (PIP2) signalling pathway. Binding of the ligand triggers a conformation 
change in the receptor, allowing the Ga subunit to exchange its resident GDP molecule 
for GTP and then dissociating from the G)3Gy complex. It then activates a cytosolic 
phospholipase C enzyme (PLCp) to increase the hydrolysis of phosphatidyl inositol bis 
phosphate to produce inositol tris phosphate (InsP3) and diglyceride (Janmey, 1994). 
Binding of InsP3 to its tetrameric receptor on the endoplasmic reticulum can raise 
[Ca2+]i from lOOnM to ImM (Clapham 1995). [Ca2+]i gradients have been proposed 
to initiate cell migration, but other evidence suggests that cells that are already migrating 
do not have changes in calcium concentration during chemotaxis (Laffafian & Hallet, 
1995). Diglyceride (DG) recruits cytosolic protein kinase C to the membrane in a 
calcium dependent fashion, thereby activating it against a range of substrates of which 
the best characterised is the Myristoylated Alanine-Rich C-Kinase Substrate 
(MARCKS) in the PMN and pleckstrin in the platelet. Many of the actions of the
1 1
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1 . 5 .1 .  Diversity of signalling pathways
signalling molecules can be mimicked by phorbol esters which activate protein kinase C 
directly without changing cytoplasmic calcium concentration. The neutrophil can 
respond to any one signalling molecule over a very wide concentration range, and 
because the responses at high concentrations may differ from those at low 
concentrations our interpretation requires either the presence of several different 
receptors or else the modulation of receptor concentration which could be achieved by 
storing the receptors in pools within the granule membranes. Nevertheless because 
signalling pathways share many common features it is hard to see how, for example, 
responses to IL-8, fMLP or C5b could differ in any substantial way. Some light may 
be shed on this by an analysis which shows that elevated calcium can produce a wide 
spectmm of cellular responses depending on the precise way in which the concentration 
changes with time (Berridge, 1997).
I
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Much attention has been focused on the role of the alternative pathway involving the
■■■■
activation of the phospholipase C isoform PLCy, which is recruited from the cytosol by 
phosphorylation of tyrosine residues in an integral membrane receptor protein 
(reviewed by Clapham, 1995). This isoform is able to hydrolyse a specific pool of
,PIP2 which is normally sequestered by proximity to profilin, a protein that was 
believed to control the ratio of polymerised to unpolymerised actin in the cytosol.
Phosphatidyl inositol 3-kinase (PI3K) which like PLCy is activated by recruitment to 
tyrosine phosphorylated integral membrane proteins is also known to be activated by 
fMLP and thrombin (Wennstrom et ak, 1994), and this is claimed to be essential for 
PDGF-stimulated re-arrangement of actin filaments in fibroblasts and forms the basis 
for membrane raffling and activation of the small G-protein rac. ■
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1 .5 .2 .  Priming
Priming is a process that has stimulated much debate in recent years. The release of 
superoxide by neutrophils is a response to chemotactic agents, providing they are 
present at sufficiently high concentrations. If the cells are initially exposed to a low 
concentration of the agent, then the response pattern to the high concentration is 
modified and this modification is termed 'priming'. However there are two 
interpretations of the nature of priming. One is that priming increases the sensitivity of 
all of the cells of the population to the agonist and the second is that priming sensitises a 
large population which do not respond to a single exposure of a high concentration of 
agonist. One possible cellular mechanism is that sequential release of granules increases 
the concentration of agonist receptors and PHOX enzymes in the PM. It is possible that 
priming is achieved by the release of secretory vesicles to the surface of PMN, thereby 
activating the cellular machinery to produce superoxide, without actually stimulating the 
enzyme directly (Manara et ah, 1991). Interestingly, cytochalasin B (which 
depolymerises actin filaments) is the most effective known priming agent, but its 
mechanism of action is not fully understood. The role of primary granules is central to 
the study of priming because unlike the other granules, they are not released in an 
unprimed cell. This suggests that components released to the cell surface by the early 
granules play a dominant role in priming for late granules. Ackerman and colleagues 
(1993) have shown that integrins arrive at the surface of adherent cells in discrete 
clusters, consistent with local vesicle fusion, One possible mechanism is that early 
vesicles which carry integrins also transport to the surface a component that is essential 
for the degranulation of primary vesicles. Because CD45 is not present on untreated 
cells, or is present at very low levels, and has a large number of potential targets, 
priming may be associated with its release to the plasma membrane.
Before degranulation of primary vesicles, there is an increase in the concentration of 
cGMP (Wyatt et al., 1993), and an activation of a kinase which phosphorylates
13
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vimentin, facilitating the degranulation. It is of interest that this phosphorylation and the 
change in cGMP concentration does not happen to cells in suspension, and conversely 
cytochalasin B is not required for degranulation of adherent cells. As both cytochalasin 
B and the phosphorylation of vimentin are likely to cause cytoskeletal re-organisation, 
one or the other is probably required for degranulation.
1 . 5 . 3 .  Signalling by arachidonate metabolites
The neutrophil (and other myeloid cells) reinforces the initial signalling mechanisms by 
generating powerful signalling species derived from arachidonate. The most important 
of these are the prostaglandins and the leukotrienes which are derived from 
arachidonate by the actions of the enzymes cyclooxygenase and lipoxygenase 
respectively. Both types of molecules have very diverse and largely proinflammatory 
actions. Some prostaglandins are known to be hyperalgesic (dolor) and one of the 
leukotrienes, LTB4, is a very potent activator and chemotactic agent for neutrophils. 
Thus generation of these lipid signals is one of the positive feedback loops in 
inflammation. Because the production of all of these species requires arachidonate to be 
mobilised from membrane phospholipid, much attention has been paid to the enzymes 
involved in this process. Most of the early evidence indicated that release was due to 
phospholipase A2 (PLA2) activity, but other pathways exist and there is evidence that 
mobilisation may require an initial cleavage by either PLC or phospholipase D (Zhou et 
al., 1993). The demonstration that lipocortin 1, produced in response to glucocorticoid, 
strongly inhibited arachidonate mobilisation suggested a firm link between steroid 
action and the production of arachidonate metabolites.
1 . 5 .4 .  Summary
In summary there is a cascade of co-ordinated responses to a single signalling 
mechanism which produces cell polarisation, diapedesis, chemotaxis and phagocytosis
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which involves a co-ordinated degranulation process in which this process itself 
contributes to the upregulation of signal receptors.
stimulation of motor activity is such that PMN become the fastest moving of all 
mammalian cell types.
The earliest observed response is the uncapping of barbed ends of filaments which 
leads to a burst of nucléation activity near to stimulated receptors (Howard et al., 1990, 
Watts et al., 1991, Coates et al., 1992). The initial increase of F-actin is a symmetrical 
accumulation at the cell periphery, followed by development of asymmetry and finally 
by a change from spherical to polar (Watts et al., 1991). Stimulation of cells causes 60- 
80% of G-actin to polymerise, effectively doubling the quantity of F-actin (Cassimeris 
et al., 1992). It is quite clear that these changes involve stimulation of motor activity, 
but the organisation of motors within complex actin meshworks is poorly understood.
1 . 6 . 1 . 2 .  Bundling of Filaments
15
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1 .6 .  Moi-phology
1 . 6 . 1 .  Shape changes (polarisation)
In suspension PMNs are spherical with slight membrane ruffling but, when stimulated 
by chemotactic agents they elongate and develop a polar shape similar to that of attached 
cells (Coates et ak, 1992). This is accompanied by an increase in volume of around 
20% (Grinstein, 1986), around 2/3 of which is due to sodium influx. The degree of
1 . 6 . 1 . 1 .  Involvement of Actin
s
Elongating actin filaments are crosslinked to form networks and bundles. Condeelis 
(1993) has argued that the random nature of these arrays would prevent myosin 
mediated sliding causing the filaments to expand in a mode consistent with pseudopod
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formation. Unphosphorylated MARCKS is known to crosslink actin networks at the 
membrane, but this is inhibited either by phosphorylation or by calmodulin binding 
(Aderem, 1992). This would provide a credible mechanism for modulating actin 
dynamics provided that the signal itself was periodic e.g. if cytosolic calcium levels 
oscillated in response to a persistent signal (Berridge, 1997).
1 .6 .2 . Time course of responses
Up to 45 sec after stimulation with fMLP there are no observed changes in PMN 
morphology or in their distribution of actin; however by 90 sec the actin distribution is 
asymmetrical in 95% of the cells and by 120 sec most of the cells have developed an 
actin rich pseudopod which is much thinner than the cell body (Coates et ak, 1992). 
The duration and extent of actin polymerisation is the major determinant of the degree 
of polarisation of PMNs (Watts et ak, 1991). Initially the F-actin concentration is 
lowest in the pseudopod (suggesting that microtubules may be important for the early 
stages of pseudopod formation), but by 5 minutes polymerised actin is more 
concentrated in the pseudopod than in the cell body.
Colocalisation of F-actin and a-actinin at the front of a migrating neutrophil may favour 
the extension of pseudopods, the combination of F-actin and myosin at the tail may be 
the basis for contraction towards the tail and for forward cytoplasmic streaming; tubulin 
is all but absent at the tail of migrating PMN (Keller and Niggli, 1993).
1 .6 .3 .  Signal transduction affecting actin dynamics
Recent work has shown that rac and rho G-proteins play a vital role in the 
determination of morphology of actin polymerisation and hence of cell shape (Allen et 
al., 1997), although little of this work has been earned out with PMN.
16
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1 . 6 . 4 .  Role of microtubules
Selective stabilisation of microtubules can generate microtubule-based cell asymmetry
17
PI3-kinase activation is essential for PDGF-stimulated re-arrangement of actin filaments 
that causes membrane ruffling (in fibroblasts); this enzyme has an SH2 domain which 
binds to phosphotyrosine in target proteins and thereby causes its activation 
(Wennstrom et al., 1994). Wortmannin inhibits both PI3-kinase activity and it also 
inhibits PDGF stimulated membrane ruffling in fibroblasts and the fMLP induced 
metabolic burst in PMN. ra d  has been implicated as a downstream event in this 
process (Wennstrom et al., 1994). Hence it seems plausible that the synthesis of PIP3 
(and other PI3K products) may activate rac either directly or indirectly in these cells. 
Because rac is a small G-protein this regulation could be mediated via the guanine 
nucleotide exchange proteins (Wennstrom et ak, 1994); Ridley & Hall (1992) have 
suggested that rac and rho may be involved in modulating PI turnover and, in this 
respect, it is interesting that the p85 subunit of PI3-kinase has a rhoGAP-like domain
(stimulates hydrolysis of GTP).
Microtubules are not easily studied in the neutrophil, due to the small size and 
convoluted shape of the nucleus. However, a number of workers have produced 
evidence that microtubules have a role in the control of cell shape in PMNs.
1
(Gunderson & Bulinski, 1988). Microtubules parallel to a chemotactic gradient
.elongate, with those perpendicular shorten (Anderson et ak, 1982). Those microtubules 
which point to the leading edge may have been recently stabilised, consistent with an 
increasing number of microtubules being de-tyrosinated with time (Gunderson &
Bulinski, 1988). However, there are still dynamic tyr-microtubules at leading edge, and 
this is consistent with a second messenger only effecting a small number of stabilising 
factors. Disruption of microtubules leads to a loss of directionality of movement, 
demonstrated by wide angles of turn. Selective stabilisation of microtubules in the
si:
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direction of migration would be important in maintaining directionality. Microtubules 
do not provide the vector of locomotion but rather stabilise and orient the 'baggage' 
(Malawista & De Boisfleury Chevance, 1982). Microtubules are important for accurate 
turning and for maintenance of cell shape and polarity of moving cell (Gunderson & 
Bulinski, 1988).
1 . 6 . 5 .  Interactions between Cytoskeletal Components
Microtubules can interact with actin and intermediate filaments, communicating polarity 
and asymmetry infoiTnation to the rest of the cytoskeleton. Equally, actin networks can 
influence microtubules (Euteneur & Schliwa, 1985). Changes in the axis of cell polarity 
and direction of movement would have to involve highly orchestrated conditions which 
polymerise and depolymerise microtubules simultaneously within the same cell 
(Anderson et al., 1982). Microtubules do not set up polarity, but reinforce polar 
organisation set up by the cell cortex. Once the centresome is set up behind the leading 
lamella it tends to exert a constraining influence on the cell's ability to turn (Euteneur & 
Schliwa, 1992). Cortical tension generated by the contraction of microfilaments might 
be opposed by microtubules and might maintain cell shape (Keller et ak, 1984). 
Reorganisation of microtubules following fMLP may be a weak signal for activation of 
motile apparatus; co-ordinated interactions between actin, microtubules and intermediate 
filaments (Keller et ak, 1984).
1 .7 . Cell motility
Because of the random nature of arrays, it is unlikely that myosin will be able to 
mediate sliding of filaments to expand the volume of networks to form a pseudopod 
(Condeelis, 1993). Myosin light chain kinase is phosphorylated when neutrophils are 
stimulated by fMLP. If there is a focal depolymerising of cortical actin then contraction 
of MLCK / F-actin would increase core pressure and squeeze actomysin dependent
18
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flow of cytoplasm towards the weakened area of cortex (Anderson et ak, 1982). The 
pseudopod therefore will form at the zone of least actin initially, followed by 
polymerisation in the end of the developing pseudopod.
A transient cAMP elevation may be indicative of microtubule reorganisation in general 
associated with chemotaxis but not in the pathway of signal transduction (Keller et ak, 
1984), as increasing cAMP inhibits chemotaxis (Downey et ak, 1991). Activation of 
PKA is essential for changes in shape and motility, with a threshold level of cAMP 
required for activation of PKA (Downey et ak, 1991). PKA phosphorylates MLCK, 
reducing its interaction with calmodulin and thereby interfering with the 
phosphorylation of myosin P-light chain which is essential for the activation of myosin 
(Downey et ak, 1991). Inhibition of MLCK by phosphorylation, with a consequent 
loss of myosin activity destabilises the microfilament lattice and cause it to disassemble 
(Downey et ak, 1991).
1 .8 . Phagocytic killing mechanisms and tissue injury
19
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Killing by neutrophils is largely believed to occur in the phagolysosome. There is good 
evidence however that small quantities of the killing agents are released and can damage 
host tissues, over and above the damage produced by protease activity involved in 
neutrophil migration (Weissmann et ak, 1972). The majority of tissue injury is caused 
by the release of oxidising agents (O2", hydrogen peroxide, etc.) and digestive 
enzymes. The process of phagocytosis requires that internal granules fuse with the PM 
to form a phagosome which is then rapidly internalised. Thus exposure of the granule 
membrane and granule contents to the external medium is unavoidable.
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1 .9 .1 .  The phagosome oxidase (PHOX)
The enzyme responsible for the respiratory burst is the NADPH oxidase located in the 
plasma membrane. The oxidase is formed by components arranged in an electron 
transport chain where the flavoprotein acts as NADPH dehydrogenase-cytochrome b 
reductase. Cytochrome b^gg would finally reduce O2 with formation of 0 2 " (Rossi, 
1986). Cytochrome 6553 is the only membrane protein required for activity (Segal & 
Abo, 1993), most cytochromes only contain a single subunit (p21 phox). The 13- 
subunit is a heavily glycosylated FAD-containing flavoprotein dehydrogenase 
(gp91phox).
During phagocytosis, only the enzyme on the portion of the membrane which is 
invaginated and forms the phagosome is activated. This allows the foimation of oxygen 
compounds in a strategic position for killing of ingested organisms. Soluble stimuli
2 0
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1 . 9 . The respiratory burst
The phagocytic killing mechanism which is most accessible to study is the generation of 
active oxygen species. This has largely come about as a consequence of the 
development of luminometry in which the reaction of active oxygen species with 
detector molecules is assayed by light emission. This is an extremely sensitive method 
which can be applied to intact cells. Although it might be advantageous for neutrophils 
to produce superoxide ions for some considerable length of time (probably hours rather 
then minutes), luminometry assays show that the response of neutrophils (in 
suspension) is characterised by a short burst of activity which decreases quite rapidly 
and production of superoxide which stops within a matter of minutes (Black et ak,
1991). A more prolonged period of oxidative output to inactivate plasma components 
and to activate secreted enzymes would increase the destruction / killing of bacteria 
(Nathan, 1987).
Introduction
activate the oxidase throughout the plasma membrane. The activation is associated with 
a redistribution of the enzyme in and to the plasma membrane (Rossi, 1986), with 
superoxide only being produced by the membrane in contact with the article being 
phagocytosed. A lag period allows for the vacuole to be closed before the O2" is 
produced, and so prevents release of reduced oxygen to the exterior (Segal & Abo,
1993).
The first intermediate of oxygen produced is the superoxide ion which is released 
outside the cell or inside the phagosome. Superoxide is highly reactive, but unstable 
and undergoes spontaneous dismutation to form hydrogen peroxide. Eukaryotic cells 
and aerobic bacteria contain the enzyme superoxide which catalyses this reaction. 
However hydrogen peroxide is also damaging to cells and is itself removed by catalase 
or peroxidatic mechanisms (Rossi 1986). The killing action of superoxide is also 
greatly enhanced by a secondary mechanism. Neutrophil granules contain the enzyme 
myeloperoxidase (MPO) which catalyses the formation of hypochlorite (HOCl) from 
superoxide and chloride ions, (Vilim & Wilhelm, 1989). HOCl is one of the most 
powerful bactericidal agents known.
Respiratory burst termination factors limit PMNs ability to produce superoxide ions and 
so protect normal tissues from neutrophil derived oxy-radicals. Bacterial destruction 
would be enhanced and normal tissue necrosis be controlled by prolonging the 
oxidative burst (Black et al, 1991) providing that the burst is confined to a limited area.
Nathan and colleagues (1987) showed that the metabolic burst was greatly enhanced 
both in duration and magnitude of response when the neutrophils were adherent to 
surfaces coated with extracellular matrix components.
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1 . 9 . 2 ,  Effects of drugs on NADPH oxidase
Some NSAIDs decrease luminol dependent luminescence via direct action on MPO 
reactions which is reduced possibly by their anti-oxidant properties (Vilim & Wilhelm, 
1989). Aspirin inhibits the production of prostaglandins (Vane, 1971), as do over 40 
other NSAIDs in use. Aspirin inhibition of prostaglandin H2 synthesis (coxll) 
produces 15 hydroxyeicosatetraeinoic acid (HETE) which is metabolised to 
14,15diHETE - a potent inhibitor of the metabolic burst (Cronstein & Weissmann, 
1995). Proximity to prostaglandins released from endothelial cells may limit 
sequestration of PMNs and subsequent tissue injury away from the site of inflammation 
(Downey et al., 1991). All NSAIDs inhibit aggregation via CD 1 lb/CD 18. Some inhibit 
enzyme release /02 “ (Cronstein & Weissmann, 1995). Sodium salicylate and piroxicam 
block pertussis toxin effects on aggregation / O2" inhibition, suggesting that the drug 
interferes with binding of toxins to the a-subunit of heterotrimeric G-proteins thereby 
blocking the formation of DAG that follows cell activation (Cronstein & Weissmann, 
1995).
1 . 9 . 3 .  Cytoskeletal involvement
rac may serve to co-ordinate the NADPH oxidase with phagocytosis (in vivo) (Hall et 
al., 1993) involving changes in polymerised actin at the plasma membrane (not 
dissimilar to the observed ruffles in fibroblasts). Activation may involve the movement 
of: the cytochrome from specific granules, PKC, or flavoprotein from cytosol to PM 
(Rossi 1986), although the proportion of cytochrome 6553 associated with the 
cytoskeleton does not alter with activation (remaining at 15%) (Woodman et ak, 1991); 
cytochrome 6553 is also located in specific granules which fuse with the plasma 
membrane replenishing stocks of this and other molecules when required (Segal & 
Abo, 1993).
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p47phox is phosphorylated on a serine residue allowing activation (Hallett & Lloyds, 
1995). and transportation to the plasma membrane, where it binds to cytochrome bg^g 
(Segal & Abo, 1993), activating the oxidase. 0 2 “ production can take place in the 
absence of p47phox, and so therefore is not a component of oxidase as such 
(Woodman et ak, 1991), but it is required for initial activation.
Extracellular factors that induce 0 2 “ also induce membrane ruffling and it is possible 
that rac proteins play a co-ordinating role in regulating both processes with different 
actin binding proteins being specifically recraited by rac and rho to the sites of actin 
polymerisation thereby dictating the localisation of the NADPH oxidase (Ridley & Hail,
1992). With three quarters of the oxidase components associated with the cytoskeleton, 
this would allow local activation of the oxidase in the cell rather than a stimulus 
producing a total cell response (Woodman et ak, 1991). Activation of the oxidase is 
associated with movement of rac, unaccompanied by rhoGDI to the membranes. A 
complex of rho, p47phox and p67phox docks with the flavocytochrome inducing a 
conformational change favourable to electron transport (Segal & Abo, 1993).
A';.
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IMore than 95% of the detectable 02“ activity is associated with triton insoluble fractions and so most of 0 2 “ forming activity in PMA activated is associated with the 
cytoskeleton (Woodman et ak, 1991).
1 . 9 . 4 .  Activation of the oxidase
The respiratory burst begins when 10-20% of fMLP receptors are occupied, the 
magnitude of the response depending on the rate of binding; continuous new 
interactions are required between receptor and agonist for maintaining the level of 
response (Rossi, 1986). PKC has a high affinity for PS containing membranes, and 
there is a marked increase in negatively charged phospholipids on the cell surface
-'i-during the first three minutes of PMA stimulated activation (Tauber, 1987). As well as
■
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NADPH being generated by HMP shunt, there is also one proton generated for each 
electron required to reduce oxygen. This proton is removed either via a sodium - proton 
antiporter (Tauber, 1987), or by a proton - lactic acid cotransporter (Simchowitz & 
Textor, 1992) which controls pH intravacuolarly.
1. 10 .  Defensins
Defensins constitute more than 5% of the total PMN protein, and are antimicrobial and 
cytotoxic peptides that contain 29-35 amino acids, including 6 highly conserved 
cysteine residues that form 3 intramolecular disulphide bonds (Tamura et ah, 1994). 
The abundance of defensins in specialised host defence cells of the blood and lungs 
suggest that defensins could play a role in innate immunity to infection (Kagan et ah,
1994), perhaps being responsible for oxygen independent microbial killing (Yomogida 
et ah, 1996), by forming voltage-regulated channels in the susceptible cell's membrane 
(Kagan et ah, 1994; Wimley et ah, 1994). Phagocytosed bacteria would encounter high 
concentrations of defensins (Ganz & Lehrer, 1994). At high concentration, defensin 
can remove the inhibitory effects of serum proteins on eiastase and cathepsin G 
(Panyutich et ah, 1995), as well as inactivating protease inhibitors such as a l  
antitrypsin.
Defensins increase the expression of GDI lb, C D llc and ICAM-1 on PMNs 
(Panyutich et ah, 1995), but inhibit superoxide release during phagocytosis of 
opsonised zymosan, without altering the ability to bind the opsonised particle 
(Yomogida et ah, 1996).
There is a leakage of defensins during phagocytosis (10-20% of total defensins) 
suggesting that there may be a modulatory function of PMNs behaviour at sites of 
inflammation (Yomogida et ah, 1996). Lack of defensin transcription can be a cause of
f
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CGD (more correctly referred to in this case as SGD - specific granule deficiency). 
(Tamura et al, 1994)
1 .1 1 . Chronic inflammation
Acute inflammation is almost always beneficial (as seen by the morbidity of inherited 
leucocyte adhesion molecule deficiency diseases and chronic granulomatous disease 
(where phagosome oxidase cannot be activated). However in many conditions 
inflammation does not stop once the injury has been resolved and inflammation is then 
said to be chronic. A positive feedback state is initiated whereby more PMNs / 
monocytes / macrophages are recruited and hyperactivity of these cells causes severe 
damage to connective tissue (Woodman et al., 1993), and may initiate a new immune 
response in its own right.
1 .1 1 .1 . Control of inflammation
1 .1 1 .1 .1 .  The role of steroids (corticosteroids / glucocorticoids)
Steroids have a four-ring core structure, the last of which is generally a five carbon 
ring.
Side-groups, and double bonds within the rings produce different effects, but as a mle, 
there is no relation between structure and function in steroids (Stryer).
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Steroids fall into two main categories, sex steroids and cortico-steroids. Both can be 
produced by the adrenal cortex, but only cortico-steroids have been shown to produce 
PMS (Stevenson, 1976). The primary effects of steroids is on gene expression rather 
than enzyme activation or transport processes, with the site of action being the cell 
nucleus rather than the PM. Dexamethasone has a receptor in the cytosol which 
migrates to the nucleus after activation by dexamethasone binding, where it binds to a 
limited number of bases of DNA (Stiyer).
Abundant evidence has accumulated to show that steroids of the class of 
glucocorticoids are major physiological down-regulators of inflammatory processes. 
First to be studied was cortisol itself, but many synthetic glucocorticoids have been 
synthesised and among these, hydrocortisone, dexamethasone and prednisolone have 
gained especial prominence. Arthritis and asthma are the best known examples of
debilitating chronic inflammatory states. The initial discovery of the anti-inflammatory 
effects of cortisol lead to its widespread use in the treatment of arthritis. However the 
spectacular symptomatic relief produced by initial treatment was followed by 
horrendous side effects. Although steroidal drugs are of great value as topical inhaled 
drugs, systemic steroid treatment is fraught with hazardous side effects. One of the 
major efforts in inflammation research has been to identify the pathways of steroid 
action with the hope that the beneficial and harmful responses to steroids may be 
mediated by different intermediate molecular species. If this were the case then drugs 
might be devised that would mimic selected actions of steroids. However in the case of 
inflammation, steroids appeared to act by down regulating a battery of proinflammatory 
cytokines and the molecular control mechanisms do not indicate that these processes are 
separable. Thus the main thrust of drug development has been in the search for non­
steroidal anti-inflammatory drugs, NSAIDs (reviewed below).
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1 .1 1 .1 .2 . Steroid control of gene activity
Glucocorticoids have direct actions on gene expression mediated by a cytoplasmic 
receptor complex. A wide variety of transcription regulating mechanisms have been 
described, the best characterised involve the steroid receptor complex interacting with a 
regulatory domain (the GRE) or else acting by means of the transcription factors AP-1 
and NF-kB. The outcome is that mechanisms exist for the up-regulation or down 
regulation of gene expression by glucocorticoids. In a given cell type however, it may 
not be possible to select for up-regulation or down-regulation by choice of different 
corticosteroid agonists. In many tissues a major effect of glucocorticoids is to 
upregulate the production of specific proteins. In the immune system however, the 
predominant action of steroids is to down-regulate protein synthesis. Thus the 
expression of the genes for IL-1, IL-2, IL-8 in monocytes and macrophages are all 
negatively regulated by dexamethasone.
1 . 1 1 . 1 . 3 .  Possible upregulation of gene activity by steroids
The possibility that steroids upregulate the activity of some genes and that the gene 
products might be positive anti-inflammatory mediators has been raised in several 
studies, but most notably by the work of Flower and co-workers. Following an early 
observation that semm from steroid treated rats inhibited the mobilisation of arachidonic 
acid in test animals, this group was able to isolate a polypeptide inhibitor of 
phospholipase A2 action. The protein, initially called lipomodulin or macrocortin (later 
termed lipocortin) was isolated from monocytes or macrophages (Flower & Blackwell, 
1979; Russo-Marie et al., 1979). With the discovery of a family of related proteins this 
putative anti-inflammatory mediator was termed lipocortin 1. Eventually this family of 
proteins was termed the annexin family, based on their ability to bind to both actin and 
membranes in a calcium dependent manner, and so lipocortin 1 became annexin L in a  
paper that was seminal to the present study it was demonstrated that a nonapeptide
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derived from annexin 1 contained the phospholipase A2 inhibitory activity of the 
molecule and was also anti-inflammatory in an animal model (Perretti et al., 1995). The 
status of annexin 1 as an in vivo phospholipase inhibitor was later called into question 
and it is now held that this is a consequence of non specific binding of the protein to 
phospholipid surfaces which acts as a steric block to a variety of enzymes, but only at 
non-physiologically high concentrations (Davidson et ak, 1987). Nevertheless it is of 
interest that annexin 1, the only member of this family that has been reported to have 
anti-inflammatory activity is the only member to be unregulated by glucocorticoids and 
also to be secreted from a cytoplasmic pool. It is of riirther interest that secretion is by a 
non exocytotic route. The emphasis on the anti-inflammatory actions of annexin 1 has 
now shifted to studies of their effect on neutrophil / endothelial cell interactions and will 
be discussed below (Cronstein et ak, 1992).
At about the same time that annexin 1 was first characterised as a putative anti­
inflammatory product produced by myeloid cells, Stevenson showed that a factor 
secreted by monocytes and lymphocytes in the presence of glucocorticoids had a 
profound effect on neutrophil migration (Stevenson, 1974). and was initially termed 
Polymorph Migration Stimulator. Production of this factor required protein synthesis 
and the activity was sensitive to protease action. There was some difficulty in ascribing 
anti-inflammatory properties to a factor that stimulated neutrophil locomotion. This 
work was later resumed by Chettibi et al in an attempt to see whether or not the 
activities of this preparation could be attributed to the presence of annexin 1. The factor, 
now referred to as STMS (steroid treated monocyte supernatant) (Chettibi et ak, 1993) 
was shown to confer dispersive motility to the PMNs which appear to migrate across 
protein coated glass in an unusual and highly distinctive manner. The cells (when 
exposed to a uniform concentration of STMS) travel in apparently extended pathways. 
This is in contrast to the random walk induced by fMLP where the intervals (distances) 
between turning are very much shorter, but resemble the migratory pattern seen when 
PMNs migrate in a concentration gradient of fMLP. There has been some difficulty in
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carrying out simultaneous studies to see whether the effects of STMS can be 
reproduced by pure annexin 1, but the balance of current evidence indicates that these 
two molecules are unrelated. Young et al. (1997) have shown that STMS can inhibit the 
migration of neutrophils in a gradient of fMLP (Boyden chamber assays). This is of 
potential therapeutic importance as the cells may not be able to respond to other 
environmental cues and so be incapable of participating in inflammation. The potential 
side-effect of losing some immunity would have to be monitored in a clinical situation.
Induction of proteins and peptides by glucocorticoids is due to the interaction of 
glucocorticoid receptors with c-Jun and c-Fos instead of those with cytokine inducing 
promoters. The upregulatory mechanisms (API, NF-kB) are distinct from those which 
down-regulate cytokine production. This facilitates anti-inflammatory transcription, but 
not pro-inflammatory (Cato & Wade, 1996). One such protein whose synthesis is 
inhibited by the presence of steroids is macrophage chemotactic activating factor. This 7 
kD protein is normally produced in response to IL-1 or TNFa, but incubation with 
dexamethasone inhibits its transcription (Mukaida et ak, 1991). Flower has suggested 
that the anti-inflammatory effects of steroids are mediated in monocytes and 
macrophages primarily through the induction of the synthesis of lipocortin I (annexin 
I). This protein has been sequenced and cloned, but recombinant lipocortin is not 
effective against oedema formation. The anti-inflammatory effects of dexamethasone 
can be suppressed by inhibitors of mRNA synthesis and/or steroid receptors; as 
visualised by lack of induction of lipocortin synthesis (Peers & Flower, 1990).
It is known that steroids produce changes in the behaviour of monocytes, macrophages 
and PMN in vivo, but these changes all but disappear when the effects of steroids are 
investigated m vitro. For example steroids inhibit the adhesion of neutrophils to 
endothelium in vivo, but this effect is lost when in vitro experiments are performed 
(Chettibi et ak, 1994). Stevenson (1974) postulated that this effect is mediated by
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monocytes / macrophages, and that there is a substance produced by monocytes in the 
presence of steroid that alters the behaviour of neutrophils (which may be lipocortin).
Since hydrocortisone was first used by Hench et al. in clinical medicine (1948) there 
has been considerable research into the biochemistry and biology of this class of drugs. 
In the field of inflammation, the glucocorticoids especially have come under close 
investigation.
1 .1 1 .1 .4 . Investigation of the anti-inflammatory effects of steroids
In vivo experiments studying effects of steroids on inflammation have, in many cases, 
used animal models. These follow the traditional physicians' "Rule of Thumb" by 
investigating the four rumors; calor, rubor, dolor & turgor. The assays for these 
involve rectal temperature monitoring, the analysis of the rabbit ear patch assay, and the 
effect the patients report, i.e. pain. More commonly, however, assays involve the 
inhibition of inducible oedema. This involves the injection of a known antigen under 
the skin of the animal and harvesting those cells induced to migrate into the peritoneum 
later. Initially (after 3 hours) most cells observed in the induced peritoneum are 
neutrophils but by 24 hours this has become predominantly macrophages, i.e. there is 
an influx of neutrophils before macrophages (Davies & Thomson, 1975). Addition of 
steroid 24 hours before the addition of antigen, inhibits the number of cells and fluid 
that extravasate (by about 50%), but differential cell counts do not alter; the proportion 
of each cell type remains constant. It is possible that if neutrophil extravasation could be 
completely inhibited then there would be no secondary wave of macrophages.
When steroid is administered before the agonist, it has been observed that small dyes 
do not accumulate in the induced oedema (Davies & Thompson, 1975). This was 
initially thought to be due to hindering the transfer of cells from the blood to the extra­
cellular space, but the model was discounted because cell migration is inhibited more
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There is a decisive role for PEC AM (CD31) during the inflammatory response, with the
In vitro experiments examining the permeability barrier of the endothelium often utilise 
Boy den Chambers, but normally only single cell types are used. These experiments
slowly than dye leakage, the opposite of expectation if 'holes' in the endothelium were 
to be closed over a period of time. However, if the endothelium was to remain pro­
adhesive for blood cells, then they would continue to attempt to extravasate, even in the 
presence of steroid. Cronstein (1992) showed that steroid treatment inhibits endothelial 
transcription of ICAM-1 and E-selectin, thus reducing the adhesiveness of the 
endothelium. However, Youssef et al. have more recently shown (1996) that treatment 
with steroid, although reducing ICAM-1 and E-selectin have no effect on the levels of 
PECAM-1, a cell adhesion molecule required for transendothelial migration 
(Vaparciyan et ah, 1993, Muller et ah, 1993). NSAID treatment also has no effect on 
the levels of PECAM-1 expression, nor on PMN adhesion to endothelium (Gonzalez- 
Alvaro, et ah, 1996, Pellegatta, et ah, 1996).
distribution of PECAM on the endothelium altered. Endothelial cells grown in culture
have a uniform level of PECAM over most of the cell surface. However, when 
confluency is reached there is a redistribution of PECAM to the cell borders where it is 
thought to participate in the tight junctions between endothelial cells (Bevilaqua, 1993).
As described above (1.2.2) pro-inflammatory mediators can induce retraction of 
endothelial monolayers (Kaplanski et ah, 1994, Bradley et ah, 1995), and binding of 
neutrophils to the endothelium will also cause changes in endothelial conformation
■(Delmaschio et ah, 1996). This change in conformation will release unbound PECAM 
to the surface of the endothelium, which can then be bound by leukocytes (both 
neutrophils and monocytes bind to PECAM through homotypic adhesion (Luscinskas 
& Lawler, 1994)). Indeed, this binding to PECAM will increase the binding of 
CD 1 lb/CD 18 (Berman & Muller, 1995), possibly by phosphorylation of the integrin 
(Pardi et ah, 1992).
::ÿ
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mirror the in vivo experimental results, i.e. steroid therapy inhibits the movement of 
neutrophils through an endothelial monolayer grown on filters (Ward 1966 - inhibition 
of chemotaxis by 50%); Mow at & Baum (1971) and Rinehart et al (1974) say there is 
no effect in vitro. Merkow et al (1971) showed that steroid treatment in vivo does not 
inhibit the phagocytosis of bacteria, but the subsequent degranulation into the 
phagolysosome is inhibited.
1 .1 1 .1 .5 . Possible effect of steroids on vasculature
In 1956 Germuth postulated that all the effects of steroids could be explained by effects 
on the vasculature (Germuth, 1956), in accord with the vasoconstrictive effects of 
steroids on the blood vessels (Wyman et ah, 1954), and inhibition of vasodilation in 
inflamed veins (Ebert & Wissler, 1951; Allison et ah, 1955). There is also tightening of 
the junctions between endothelial cells when treated with steroids.
1 .1 1 .1 .6 . Side-effects of steroids
Side effects of steroids include retention of water and sodium, excretion of potassium, 
loss of mineral from bone leading to osteoporosis and fractures, hypertension, 
personality changes, gastric ulcers and thinning of the skin. (Cato & Wade, 1996). 
Also, patients with chronic rheumatoid arthritis and systemic lupus erythomatosus have 
antibodies (IgG and IgM) to annexin 1, especially if oral steroid has been administered. 
Oral administration of steroid may lead to steroid resistance, and there are also groups 
of people who possess innate resistance to steroids. It would appear that ingesting 
steroid orally is not the best long term solution to a problem, and as many people have 
an aversion to needles, other drugs have been developed.
1 .1 2 . Non-steroidal anti-inflammatory drugs (NS AIDs)
1 .1 2 .1 . Aspirin
32
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NSAIDs became an analgesic / anti-pyretic therapy in the early 1900s (40 years before 
steroids were first used clinically). The best known and most widely used NSAID is 
aspirin (acetylsalicyclic acid), first synthesised by Felix Hoffman in 1897. John Vane 
in 1971 showed that the anti-inflammatory effect of aspirin was due to inhibition of 
production of prostaglandins and thromboxanes. Aspirin has been described as being 
as close to a wonder drug as possible (Medical Sciences Bulletin, published by the 
pharmaceutical information associates limited), and yet it is probable that this 
compound would not be allowed to be released as a drug today because of its many and 
often dangerous side-effects (J. Lackie, personal communication). Vane’s work 
(1971), showing that NSAIDs (with the exception of salicylates, (Cronstein &
Weissman, 1995) inhibit prostaglandin synthesis, explains some of the side effects as 
prostaglandin synthesis by the endothelium inhibits neutrophil adhesion; inhibiting the 
release of prostaglandin by the endothelium induces neutrophil adhesion. Aspirin (and 
its derivatives) destroy Vitamin C, which is required to fonn strong collagen bands 
between cells, including those in blood vessels. It is possible that long term use of even 
low dose aspirin could cause subarachnoid haemorrhage by causing the formation of 
weak blood vessel walls. This results in increased incidence of strokes in patients who 
use aspirin for pain relief or blood thinning. At low doses aspirin inhibits platelet 
aggregation and interferes with blood clotting; in relatively large doses, aspirin reduces 
pain and inflammation in rheumatoid arthritis and several related diseases. (Medical 
Sciences Bulletin)
U'
Although aspirin is good for the relief of pain, the analgesic effects must be weighed up 
against the potential risks. Some possible side-effects associated with aspirin are 
stomach irritation, gastrointestinal bleeding and reduced ability to form blood clots 
(hence its use as a blood thinning agent). Therefore, aspirin is "not recommended" for 
people with stomach ulcers (although applying a coating to the aspirin can reduce 
stomach irritation), certain liver problems, gout or bleeding disorders. Aspirin has been
■
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associated with Reye's Syndrome in children using aspirin as an anti-pyretic. It is 
mainly because of these side-effects that derivatives of aspirin have had to be 
developed.
1 .1 2 .2 . Aspirin derivatives / alternatives
Acetaminophen is an aspirin alternative which has a comparable analgesic value to 
aspirin but lacks the anti-inflammatory effect. The lack of an anti-inflammatory 
component removes some of the more serious side-effects associated with aspirin such 
as gastrointestinal bleeding and decreased ability to form blood clots and certain liver 
diseases. Therefore, acetaminophen can be used by persons with ulcers and bleeding 
disorders, but is of no long term benefit if the source of discomfort is inflammation 
(treating the symptom - pain, rather than the source of the symptom). Acetaminophen 
and its brand names was the leading drug sold in the US in 1995.
Ibuprofen is an aspirin alternative which has both analgesic and anti-inflammatory 
effects. As a result the side effects associated with Ibuprofen are similar to those 
associated with aspirin: stomach irritation, gastrointestinal bleeding and reduced ability 
to form blood clots. Like aspirin, it is not recommenced that people with stomach 
ulcers, gout or bleeding disorders take Ibuprofen.
Known side-effects of anti-inflammatory NSAIDs indicate aspirin-like problems, even 
for non-aspirin derivatives. This is a major problem, as many people are intolerant of 
aspirin, and asthma sufferers (among the largest users of steroids) are "not advised" to 
take steroids by the US Food & Drug Administration. As prolonged use of steroids can 
lead to resistance, and NSAIDs can cause gastro-intestinal ulcers and bleeding safer, 
more natural products could present an answer, although these may have their own 
side-effects.
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1 .1 2 .3 . Effects of NSAIDs on PMNs
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Indomethacin and diclofenac have been shown to induce gastric ulcers, possibly due to
an elevation of TNFa causing increased neutrophil adhesion. (Appleyard et ah, 1996; 
Diaz-Gonzaiez et ah, 1995) although steroids prevent this damage. Indeed other 
NSAIDs (e.g. piroxicam) activate circulating neutrophils (Avila et ah, 1996) and induce 
release of primary granule contents (as assayed by MPO activity) in vivo, although they 
induce lower levels of L-selectin shedding, an indicator of cellular activation (Diaz- 
Gonzalez et ah, 1995). Wallace et ah (1993) showed that most of this damage could be 
prevented by blocking adhesion receptors on the endothelium, and postulated that a 
therapy to prevent ulceration could include a blocking of the interaction of neutrophils 
with the endothelium. Cronstein et ah (1994) showed that sodium salicylate inhibits 
induced adhesion of neutrophils to endothelium without altering basal levels (due to 
oxidative phosphorylation of ATP to adenosine and its subsequent release). This also 
showed that different NSAIDs operate in different manners, as indomethacin and 
piroxicam induced decreases in adhesion could not be reversed by removing adenosine.
Most NSAIDs tested have no effect on the release of secondary granule contents, 
however there are exceptions, e.g. Tenidap (Blackburn et ah, 1991). More common are 
inhibitors of the primary vesicle degranulation.
1 .1 2 .4 . Natural alternatives to steroids
It has been shown by Flower's group that one of the effects of steroids on monocytes 
is the induction of the synthesis and subsequent release of a class of compounds 
referred to as lipocoitins (annexins) (Flower & Blackwell, 1979). These have many of 
the anti-inflammatory effects of steroids, e.g. the suppression of oedema formation 
under certain circumstances (e.g. carrageenin induced) but not others (e.g. dextran
,induced). Therefore it is probable that lipocoitin cannot be the only mediator of steroid
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action, especially as lipocortin has no effect on the adhesion of neutrophils to cytokine 
activated endothelium.
1 . 12 . 4 . 1 .  Lipocortin
The initial proposal that lipocortin-1 mediates the anti-inflammatory actions of cortico­
steroids by inhibition of arachidonate mobilisation has never been satisfactorily 
substantiated or refuted. However there is some evidence that lipocortin-1 mediates the 
effects of steroids on eicosanoid synthesis rather than release. Steroids and lipocortin 
(at mg/ml quantities in vitro) both inhibit the release of thromboxane when 
stimulated with fMLP or LTC4, but not with AA nor bradykinin (due to the site of 
lipocortin action being PLA% (Peers & Flower, 1990)). It is thought however that 
steroids act directly on the cyclooxygenase / lipoxygenase enzymes and so inhibit the 
synthesis of A A metabolites more directly (Masferrer et ah, 1990), by inhibiting the 
expression (at the mRNA level) of cyclooxygenase but possibly not lipoxygenase (Cato 
& Wade, 1996). Davidson & Dennis (1989) gave evidence that lipocortin may act by 
sequestering the substrate rather than inhibiting the enzyme. PLA2 is capable of 
removing arachidonic acid from membrane phospholipids and as cyclooxygenase 
requires this as a substrate then there can be no activity of this enzyme. Recent papers 
from Flower's group have concentrated on an apparently unrelated action of lipocortin- 
1 as an inhibitor of diapedesis (Getting et ah, 1997; Tailor et ah, 1997). In vivo studies 
of neutrophil dynamics in the air pouch system show that steroids do not inhibit 
neutrophil rolling or strong adhesion, but prevent diapedesis. This activity is abolished 
by the administration of antibodies to lipocortin-I.
1 . 1 2 .4 . 2 .  Other natural factors
A 2 kD peptide was described by Koltai that was produced by macrophages in the 
presence of steroids, but very little has been published on this since. Small peptides
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with anti-inflammatory properties are increasingly being referred to as antiflammins 
(Lloret & Moreno, 1994). Also Hamann et ah (1995) published an account of a factor 
released from macrophages derived from dexamethasone treated monocytes. This 78 
kD protein has similar heat labile and proteolysis susceptible properties as PMS, but is 
many times larger.
Indomethacin, another NSAID, has similar properties to lipocortin (both inhibit 
eicosanoid release and oedema by about 2/3). Both are ineffective against PAF, 
serotonin and dextran. Koltai et al (1987) partially purified a steroid induced 2 kD 
factor from macrophages which inhibited dextran induced oedema but not carageenin 
induced (lipocortin is effective against carageenin induced oedema). Steroids are 
effective against both of these agonists. At present to mimic the effects of steroids a 
number of drugs / factors would have to be administered simultaneously, with 
unknown side-effects from cross reactivity. Indeed, it is recommended that no more 
than one NSAID be taken at any one time. As no individual NSAID gives the range of 
anti-inflammatory and anti-pyretic effects as steroids, then the patient is still going to be 
in some discomfort.
1 .1 2 .4 .3 . Adenosine
Cronstein has reviewed (1994) the role of adenosine in the inhibition of phagocytosis, 
adhesion and generation of oxygen metabolites, but not of degranulation or chemotaxis. 
That superoxide production is inhibited only if stimulated by a chemotactic factor (e.g. 
fMLP, C5a) but not by PM A suggests that adenosine acts by extracellular blockade, 
possibly involving an inhibition of priming. Firestein et al. (1995) show that inhibition 
of endothelial adenosine kinase inhibits selectin-based adhesion (important in priming). 
Adenosine may act by interfering with the interaction of E and L-selectin (as 
demonstrated by removal of sialic acid from the endothelium and pre-shedding of L- 
selectin from PMN).
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It has been suggested that adenosine acts via decrease of CD 11b induction (Cronstein & 
Weissman 1995), but this may be unlikely as initialisation of adhesion is due to 
selectins (Kansas et al., 1993), not the release of integrins to the surface. Possibly of 
greater effect is that LPS induces an increase in the level of cyclo-oxygenase enzyme, 
but dexamethasone inhibits this increase (MasfeiTer et al, 1990).
Endothelial cells have been shown to be less adhesive for PMN when cultured in the 
presence of steroids (Cronstein et al, 1992), with the effect being on the transcriptional 
control of E-selectin. Therefore when endothelial cells are challenged with a pro- 
inflammatory stimulus there is less E-selectin on the surface for PMN to adhere to.
1 .1 2 .4 .4 . Nitric oxide
Nitric Oxide is produced by a variety of cell types, with PMN and platelets being 
among the cell types with the enzyme responsible (NOS) being constitutively activated 
(reviewed by Las kin & Pendino, 1995). Conversely macrophage NOS requires to be 
activated, and has been intimated as being involved in certain inducible oedemas, 
notably carageenin. NO reacts with 02“ to produce peroxynitrite which is a longer lived 
cytotoxic oxidant. If the NADPH oxidase could be switched off, then it would be 
considerably more difficult to produce, and so tissue injury could be reduced. As 0%“ 
levels are reduced further by NO (forming the longer lived, but less cytotoxic 
peroxynitrite) it becomes apparent that control of the NADPH oxidase is of paramount 
importance. If there is little NADPH, then little NO can be produced, which cannot then 
react with 02“; the 02“ having already been produced by removing NADPH. Therefore 
a middle ground has to be reached: as NO requires NADPH as does 0%“, then making 
one molecule - peroxynitrite - on a molar basis must be a good way to reduce tissue 
oxidants (Laskin & Pendino, 1995).
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Stevenson (1974) observed that neutrophils contained in a small open-ended capillary
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1 .1 3 . STMS
7
STMS (Steroid Treated Monocyte Supernatant) was first described by Stevenson in 
1974, who called it Polymoi*ph Migration Stimulator (PMS). At this stage, the major 
pro-inflammatory cytokines had not been characterised, but later work revealed that the 
major effect of corticosteroids was to inhibit the production of proinflammatory 
cytokines, especially the chemokine IL-8. In addition, the logic of an anti-inflammatoiy 
agent that stimulated neutrophil locomotion was not clear. This work was subsequently 
resumed by Stevenson and collaborators who were able to show that the effects of 
STMS on neutrophil migration could not be attributed to the absence of 
proinflammatory agents found in control monocyte supernatant medium (CMS)
(Chettibi et al. 1993). Because the culture conditions used for production of STMS 
closely resembled those used for the production of lipocortin-I, tests were undertaken
to determine whether or not STMS activity was an attribute of lipocortin-1. Antibody 
blocking experiments proved to be negative, but in the absence of a pure sample of 
lipocortin-1 no conclusive demonstration of similarity or difference has been possible.
tube placed in a uniform concentration of this factor moved outwards to form a broad, 
weakly cohesive migration 'slug'. In contrast, migration in CMS or in control culture 
medium was far less extensive and the migration 'slug' was highly cohesive. These 
capillary migration assays required a large number of neutrophils and were both labour 
intensive and time-consuming. Chettibi et al, (1995) used the cell tracking procedure of 
Dow et al. (1987) in an attempt to simulate the results of the capillary migration assay 
from locomotion data for individual cells. The initial results, using a frame interval of 
20 seconds, confirmed that STMS stimulated apparent cell speed in comparison with 
CMS or control medium. However it was unable to distinguish between elevated 
migration speed and elevated cell persistence. This issue was resolved by the 
development of a high speed tracking system able to follow 80 cells at 5 second frame
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intervals. The results showed very clearly that fMLP, IL-8, PAF, STMS and CMS all 
enhanced neutrophil locomotion, but with very different results depending on the frame 
interval. Thus concentrations which gave the same migration speed at 5 second 
intervals gave very different values for larger time intervals, clearly relating to the 
persistence of locomotion, as indicated by track linearity. Thus it became clear that in a 
uniform concentration of these agents, long-term migration in response to STMS far 
exceeded that in response to the other factors. These results were subjected to the 
classical analysis procedure of Gail and Boone (1971) to derive the parameters of speed 
and persistence for each cell and the parameter analogous to the diffusion coefficient 
which described the spreading of the cell pellet; the action of STMS was characterised 
as the induction of highly dispersive neutrophil locomotion. Paradoxically, the effects 
of a uniform concentration of STMS on neutrophil locomotion closely resemble those 
of fMLP acting in a concentration gradient.
1 .1 3 .1 . The function of STMS
One of the perceived weaknesses of the capillary locomotion assay was that it failed to 
distinguish between the effects of enhanced locomotion and enhanced retardation by 
increased adhesion of the cells (J Lackie, personal communication). Exactly the same 
criticism applied to the modified tracking assay, but in an attempt to minimise 
population drift which could readily dominate the determination of an apparent 
population diffusion coefficient Chettibi et al. (1994) perceived that STMS enhanced 
locomotion was extremely sensitive to the tilting of the migration chamber, showing 
that the cells were very weakly adhesive. Preliminary experiments also showed that 
STMS lowered the adhesiveness of neutrophils to albumin-coated glass. STMS 
therefore acts as a direct, but not particularly powerful, stimulator of neutrophil 
locomotion, and an apparently non-specific inhibitor of cell adhesion. No model for a 
mechanism whereby reduced adhesion induces a highly dispersive type of locomotion 
has been presented.
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Although stimulation of locomotion is not an anticipated anti-inflammatory response,
■K
non-specific lowering of adhesion would be a powerful inhibitor of neutrophil 
margination. In addition STMS could cause neutrophils to move away from a tissue site 
and thus act as an agent for termination of localised neutrophil activity.
1 .1 3 .2 . Effects of STMS on the cytoskeleton
Stevenson (Thesis, 1978) argued that many of the effects of STMS could be attributed 
to disruption of microtubules (MTs) mediated by elevation of cAMP concentration. In 
adherent cells MFs extend from the periphery to a zone of MTs near the centre (Reaven 
& Axline, 1973) with MFs prominent near the focal adhesions. Bhisey & Freed (1971) 
showed that MT dismpting agents such as colchicine caused a change in motility from a 
smooth gliding to a more amoeboid, jerky motility. The tilt assay confiiTued that STMS 
caused loss of adhesion (Chettibi et ah, 1994a), but, uniquely, of the substances tested, 
caused PMNs to have a high diffusion coefficient, albeit always travelling down the 
slope. MT inhibitors reduce PMN adhesion (Lackie, 1974), and Gail & Boone (1971) 
observed neutrophils rounding up in the presence of colchicine. In contrast to this,
Conry and co-workers (1992) found that disruption of microtubules induces 
polarisation of neutrophils in suspension. Throughout these assays, the STMS-treated 
neutrophils have a characteristic morphology when viewed with phase-contrast optics, 
being elongated and predominantly phase bright (essential for the tracking assay of
■■
Dow et ah, 1987). This compares with the appearance of the control supernatant 
treatment where many of the cells are phase dark, and so not capable of being tracked.
This does not affect the results unduly, because those cells that are phase dark are
virtually non-motile. :
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1 .1 3 .3 . The structure of STMS
42
IÏ
The chemical nature of STMS has not been elucidated. Stevenson's data indicated that 
STMS was a peptide and possibly a cleavage product of a larger protein. He showed 
that the production of STMS could be inhibited using inhibitors of protein synthesis 
(cyclohexamide) and also that the activity was sensitive to protease attack. Gel filtration 
data suggested an MW >10kD. In contrast the active material was included by small- 
pore gel filtration media, indicating an MW of around 1-2 kD (Chettibi, personal 
communication). Observations of the behaviour on reverse phase HPLC indicated that 
the active particle was not especially hydrophobic and it was not absorbed by phenyl 
sepharose at high salt concentration. Similarly the activity was not absorbed by 
concanavalin-A derivatised sepharose, suggesting that it was not heavily glycosylated.
4
With the possible exception of heparin, which has been shown to have small levels of 
activity (heparin size 910, 1540 mw approx.), biologically active oligosaccharide 
containing molecules tend to be high MW species, (e.g. 150,000 kD for 
glycosaminoglycans) and are also, on the whole, pro-inflammatory. Because STMS 
reduces cell adhesion (the changes in actin being due to a reduced number of functional 
focal contacts) a short oligosaccharide could act by a simple blockade mechanism. For 
example it could interact with the L-selectin receptor in which case it could produce 
similar anti-inflammatory effects to those observed in the LAD% mutants (absence of 
functional L-selectin -Etzioni et ah, 1993) or with antibodies to selectins (Kaplanski et 
ah, 1994) or short peptides (Li et ah, 1993, 1995).
Aminosugars have also been recorded to have potential anti-inflammatory effects on 
neutrophils. Kamel et ah (1991) reported that N-acetyl-galactosamine and N-acetyl- 
giucosamine inhibit the release of elastase, and inhibit the respiratory burst. However, 
little research has been carried out since then in this area, possibly due to the effects 
being due to a quenching of enzymes released during degranulation, notably N-acetyl-
Introduction
glucosaminidase. This may explain why this aminosugar was less potent at inhibiting 
the activation of neutrophils.
Because STMS is not hydrophobic it seems improbable that it will be a lipid derivative. 
Nevertheless it is known that 12,15 (S)-diHETE is an inhibitor of neutrophil adhesion 
to IL-lj3 activated endothelium. This anti-inflammatory lipid also reduces aetin 
polymerisation within the cell (Takata et al., 1994). HETE is produced by the action of 
cyclooxygenase and lipoxygenase, which also enhances production of many pro- 
inflammatory mediators such as leukotrienes, and also of prostaglandins most of which 
are pro-inflammatory, e.g. prostaglandin E2 (Talpain et al., 1995). HETE functions by 
becoming incorporated into the cell membrane by estérification, and so should be 
removable from the medium by adding cells to it. There is a considerable body of 
evidence pointing towards LPA being a modulator of neutrophil function (Chettibi et 
ah, 1994b, Eichholtz et ah, 1993), but motility assays of this lipid indicate that in 
contrast to STMS it does not induce dispersive motility. Moolenaar's review (1994) 
indicates that most of the effects of LPA are pro-inflammatory.
1 .1 3 .4 . Purification of STMS
43
That very little was known of the chemistry of STMS meant the only reliable assay for 
the presence of the molecule in extracts was the detennination of a diffusion coefficient 
by using the modified cell tracking program. Various techniques were attempted in the 
purification STMS including filtration and ion exchange. Stevenson had previously 
shown that PMS was a protein actively synthesised (production is inhibited by adding 
cyclohexamide) by monocytes and macrophages in the presence of steroid, with an 
apparent molecular weight of 12kD to 15kD. The biological properties of PMS could be 
removed by heat treatment, and also by proteolysis (Stevenson, M.D. Thesis, 1978).
■I
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Very few assays had been attempted using partially purified material to determine the 
breadth of biological activity of STMS as the purification procedure was still evolving.
Reverse phase HPLC (SMART System, Pharmacia) and subsequent size based 
separation (Pharmacia peptide column) allowed purification to a previously 
unsurpassed level. Problems still existed with the purification, especially getting high 
enough quantities to be able to determine the amino acid composition and sequence.
One pint of fresh human blood provides less than 0.1 jag of sample. The cell tracking 
assay does not follow a 'classic' dose-response curve, and so quantification of sample 
at early stages was virtually impossible. Stevenson referred (Thesis, 1978) to high 
density mixed leukocyte cultures as producing PMS with 'high potency', but even 
these samples lose activity after diluting by any more than four fold (personal 
communication).
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Materials and Methods
2 . 1 .  Materials
A variety of salines were used throughout the course of this work (PBS, BSS, HS, 
HH), depending on the cell type, the assay being used, and the anticoagulant in the 
blood.
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2 . 1 . 1 .  PBS (Phosphate Buffered Saline)
8g Sodium Chloride, 0.2g Potassium Chloride, 1.15g Disodium Hydrogen 
Orthophospate and 0.2g Potassium Dihydrogen Orthophosphate were dissolved in 
water, the pH adjusted to 7.4 and made up to IL before sterile filtering into aliquots.
2 . 1 . 2 .  BSS (Balanced Salt Solution)
8g Sodium Chloride, 0.4g Potassium Chloride, Ig Glucose, 0.2g Magnesium Chloride 
(6H2O), 0.2g Magnesium Sulphate (7H2O), 0.14g Calcium Chloride, 0.06g Potassium 
Dihydrogen Orthophosphate and 0.24g Disodium Hydrogen Orthophosphate were 
dissolved in water, the pH adjusted to 7.4 and sterile filtered into aliquots before 
storing at 4°C.
i
2 . 1 . 2 .  HS (HEPES Saline)
2.38g HEPES, Ig Glucose, 8g Sodium Chloride and 0.4g Potassium Chloride were 
dissolved in water, the pH adjusted to 7.4 and sterile filtered into aliquots before 
storing at 4^C.
2 . 1 . 3 .  HH (Hanks' HEPES)
As HS but containing ImM Calcium Chloride and Magnesium Chloride. i
2 . 1 . 4 .  HO (HEPES Water)
-
5.25g HEPES were dissolved in water, the pH adjusted to 7.4 and dispensed into 
aliquots before autoclaving and storing at 4^C.
Î
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2.1.5.  Antibiotics
A solution of L-Glutamine (29.2g/L) was made up in water, and sterile filtered. A 
solution of Streptomycin Sulphate (76.2mg/L) was also made up in water. 150ml 
(200mM) Glutamine solution, 100ml Streptomycin Sulphate and 12.5ml Amphoterisin 
B were mixed, aliquoted asceptically and kept frozen until use.
2 .1 .6 .  Ham's F I0 Culture Medium
180 ml HO, 1ml 7.5% Bicarbonate solution, 5ml Antibiotic, 20p,l Steroid (lO-^M 
Dexamethasone), 20ml Foetal Calf Serum asceptically added to a bottle and mixed 
gently. For monocyte culture, Ham's FIO was also made up without serum for final 
stage of production of STMS.
2 . 1 . 6 . 1 .  Trypsin/ Versene
Versene was made up essentially as for HS (2,1.2) except that 0.2g / L EDTA was 
added before adjusting the pH to 7.5. The versene was then dispensed into 20ml 
aliquots prior to autoclaving and storage at 4°C. Immediately before use, 0.5ml of 
sterile 2.5% solution of trypsin (Gibco) was added to the versene and mixed.
2 . 1 . 7 .  PAGE 
Electrophoresis Buffers
2.1.7.1. Upper T ank Buffer x5
31.6g Tris Base (Tris[Hydroxymethyl]aminomethane), 20g Glycine and 5g Sodium 
Dodecylsulphate (SDS) were dissolved in water, and made up to 1 litre with distilled 
water.
2 .1 .7 .2 .  Lower Tank Buffer
60.5g Tris Base and 5g SDS were dissolved in water, the pH adjusted to 8.1 and made 
up to 1 litre with distilled water.
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2 . 1 7 .3 .  Running gel buffer 
18.15g Tris Base and 0.4g SDS were dissolved in water, the pH adjusted to 8.9 and 
made up to 100ml with distilled water.
2 .1 .7 .4 .  Stacking Gel Buffer
5.9g Tris and 0.4g SDS were dissolved in water, the pH adjusted to 6.7 and made up 
to 100ml with distilled water.
Electrophoresis
7.5% polyacrylamide gels (12ml of 28.5% acrylamide solution / 1.5% bis-acrylamide,
12ml running gel buffer, 24ml distilled water, 20|il TEMED, 150|xl 1% ammonium 
persulphate) were freshly prepared with a 5% stacking gel (4ml 28.5% acrylamide /
1.5% bis-acrylamide solution, 6mi stacking gel buffer, 14ml distilled water, 20jii 
TEMED, 200|ll 1% ammonium persulphate). The samples were prepared in boiling 
mix (2.5ml stacking gel buffer, 0.5ml Mercaptoethanol, Ig Lauryl Sulphate, 0.5ml 
Glycerol, 1% Bromophenol Blue made up to 10ml with distilled water), applied to the
■
gels and run at 25 inA. The gels were then prepared for silver staining, by washing in 
destain (5% methanol, 10% acetic acid in distilled water) for 30 minutes before fixing 
in 10% Gluteraldehyde (Aldrich) for a further 30 minutes. The gels were then washed 
overnight in distilled water (3 changes of water) and stained (19% silver nitrate 
(Sigma), 4ml Ammonia, 21ml 0.36% NaOH, 46ml distilled water). Three washes of 
distilled water over a ten minute period were applied and the gel developed using 
formaldehyde, citric acid. The developing was stopped using Amfix (diluted 1:3 v/v 
with water) for 1 minute and the gel washed thoroughly before photographing.
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I2 .2 . Cell Isolation & Culture
2 .2 .1 .  Preparation of Polymorphonuclear Leukocytes
Venous blood was collected over heparin (25 units /ml blood), and red blood cells were 
sedimented with 20% v/v of a 5% w/v solution of dextran 500 (Sigma) for 30 minutes.
5
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The leucocyte-rich upper layer was aspirated off and carefully applied over an equal 
volume of Nycoprep 1.077 (Nycomed) and centrifuged at 800g for 15 minutes. The 
upper plasma, mononuclear cell and Nycoprep layers were removed and discarded. The 
pellet was then subjected to brief hypotonic lysis to remove contaminating erythrocytes.
The yield from this procedure was 5 x 10  ^cells per ml of blood and the purity of the 
population, checked by microscopy was > 90%. Viability was routinely assayed by 
trypan blue exclusion, with viability generally greater than 95%.
A;
i
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2 .2 .2 .  Culture of Monocytes. The production of STMS and CMS
2 .2 .2 .1 .  Preparation of monocytes from whole blood
Whole blood was sedimented with 5% dextran solution as per PMN purification, with 
the monocyte layer (fig. 2) being removed and washed twice. To remove contaminating 
lymphocytes and platelets the cells were cultured in Ham's FIO supplemented with 5% 
foetal calf serum (Both Gibco) for 1 hour at 37^C to allow monocytes to adhere to the 
surface of the culture vessel. The non-adherent lymphocytes and platelets were 
removed by three washes with HS. Initially, the adherent monocytes were then cultured 
in FIO medium containing 5% FCS for a further 24 hours. Subsequently, the culturing 
was carried out in serum free medium to facilitate purification of the active factor. In a 
recent modification this process was taken one step further with the monocytes being 
cultured in a serum free HH medium, thus removing a large number of potential 
contaminants, notably vitamin B 12, from the STMS. The supernatant was drained off 
and filtered through 0.22|Lim Millipore filters before use / purification.
■4
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top layer of sedimented 
blood is layered onto Njteoprep and centrifuged at SOOg for 15 minutes
neutrophil rich f  pellet used for '% most assays.I monocyte rich middle latter used for culture
Fig. 2 Granulocyte preparation
2 .2 .2 .2 .  Preparation from Buffy Coats
1. Standard Buffy Coats. Buffy coats were layered directly on to an equal volume of 
Nycoprep 1.077 and centrifuged at 800g for 20 minutes before aspirating the monocyte 
layer, then followed by the procedure described above. This procedure was hampered 
by the fact that many of the cells in the buffy coat clumped either before or during the 
purification resulting in poor yields of monocytes and STMS.
2. Buffy coats prepared by a modified procedure involving lower speed centrifugation 
did not suffer from the same clumping problem and thus produced a much higher yield 
of monocytes. The purification of monocytes from these buffy eoats was exactly the 
same as above. When pints of blood (or buffy coats) were used for the culture of 
monocytes the anticoagulant was normally acid citrate dextrose. In consequence the 
blood clotted if the media used to wash the cells contained divalent cations Hence the 
first two washes were always carried out PBS or HS.
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2 .2 .3 .  Culture of Endothelial Ceils
Human umbilical vein endothelial cells (HCJVEC) were isolated essentially according to 
the method of Jaffé (1973). Fresh umbilical cords were collected from the Labour suite 
of the Queen Mother’s Maternity Hospital, Glasgow and stored in BSS until ready for 
use. The cords were flushed gently to remove blood, and filled with Img/ml 
collagenase type IV(Gibco) in DMEM and clamped at either end. After 15-20 minutes 
incubation the collagenase was collected, the cord re-clamped and gently massaged to 
remove the endothelial cells. The eells were then flushed out with DMEM 5% FCS and 
washed three times before plating. After 24 hours the cells were washed with HS pre­
warmed to 37^C and cultured in endothelial cell growth medium (ICN Clonetics). This 
culture medium contains dexamethasone, 1% FCS, undefined growth factors, and is 
suplemented with a further 4% FCS (Gibco). The cells were subcultured 2-4 times 
(using Trypsin / Versene) before use. Where steroid treatment of the HUVEC was not 
required, the cells were maintained in steroid free FIO for 2-3 days before use with 2 
changes of medium.
2 .3 .  Labelling Cells
2 .3 .1 .  Radiolabelling of PMNs
PMN were suspended at 10 million per ml and 100 jiiCi Na^^Cr (Amersham) was 
added and incubated for 45 minutes at 37^C. The cells were shaken 3-4 times during 
the incubation period. The cells were washed at least twice with warm BSS 0.5% BSA 
(Sigma), or until supernatant counts were essentially at background, before assaying.
2 .3 .2 .  Fluorescent Labelling of PMNs
An alternative to ^^Cr was to use Carboxyfluorescene di-Acetate (CFDA) (Sigma) 
(4jig/ml final concentration). The procedure was essentially the same as radiolabelling, 
except the cells were physically counted using fluorescence optics on a Leitz 
microscope. Neutrophils were incubated in the presence of 4jig/ml CFDA for 30 
minutes at 37®C with constant stirring. The cells were centrifuged at 2,000 rpm for 5
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minutes and washed three times before use with Hanks HEPES containing 0.1% BSA ■ I
(Goodall & Johnson, 1982; Li et ah, 1993).
2 .3 .3 .  Staining of F-Actin
PMNs were allowed to adhere to BSA (1%) coated coverslips for 20 minutes before 
treating with agonist for 20 minutes and fixing with 1% para-formaldehyde for 60 
minutes. The cells were washed twice with PBS 1% BSA before permeabilising with 
1% Triton (Sigma) in PBS. The cells were washed a further twice before staining with 
TRITC-Phalloidin (Sigma) O.ljLtg/ml for 15 minutes (in the dark) and washed 
thoroughly with PBS before mounting. Cells were analysed using confocal laser 
scanning microscopy with computer imaging of cells using the Metamoiph program. Z~ 
series composite images were used to visualise total F-actin content within the cells.
i .
2 .4 .  Adhesion Assays 
Radiolabelled neutrophils were added to coverslips or multi wells coated with either 
BSA, BAE or HUVEC. The coverslips / multiwells were then incubated at 37®C for 30 
minutes before gently rinsing to remove unbound PMN. The agonist was then gently 
added to the cells and returned to the incubator for a further 15-20 minutes. Wells / 
coverslips were washed gently three times to remove PMNs that were unbound. The 
specific radioactivity from each coverslip was then counted using a WILJ gamma 
counter 2001. If multiwells were used, then the cells were lysed with lOOmM NaOH 
for 20 minutes before aspirating the supernatant and measuring the specific activity as 
above. This method has the advantage of not scratching any cells off of the surface of 
the coverslip when removing the coverslip from the dish. As an alternative to 
radiolabelling cells were labelled using CFDA as described in section 2.3.2 and counted 
manually. I
2 .5 .  Electron Microscopy 
For scanning electron microscopy, cells were fixed in 2.5% gluteraldehyde (Sigma) in 
isotonic sucrose for 1 hour before washing twice in isotonic sucrose. The cells were
J
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then post-fixed in 1% w/v osmium tetroxide (Sigma) in isotonic sucrose buffer, 
washed and stained with 0.25% w/v aqueous uranyl acetate for 1 hour in the dark. The
'■ '-Ï
cells were washed with water then dried either through a graded series of alcohols or 
acetones and critical point dried. When the PMN were treated in suspension, the 
acetone drying was performed with the cells sandwiched between 2 |im filters 
(Millipore) in a Swinney adapter. In some cases these filters were shaken on to double 
sided tape to ensure cells were not lost during the later stages of drying. The cells were 
mounted on aluminium stubs and sputter coated with a layer of gold using a modified 
Polaron E5000 sputter coater prior to viewing in a Phillips SEM (PSEM 500).
Commonly a gold film of between 200 and 500 Angstroms was used. Images were 
captured using a camera mounted directly to the microscope or with a computer 
connected. It was noted that during the drying stages a large amount of shrinkage can 
occur (e.g.. up to 40% in some lymphocytes), and some proteins are dissolved during 
critical point drying, including microfilaments.
V
f2 .6 . Analysis of the Respiratory Burst
The respiratory burst was recorded by incubating neutrophils at concentrations of 10  ^
per ml at 37®C for 30 minutes in LKB Wailac 1251 Luminometer before the addition of 
Luminol and PMA 0.1|ig/ml or fMLP lO'^M (all Sigma). The results were 
continuously recorded utilising a custom computer program. The addition of Iqg/ml 
w/v cytochalasin B (Sigma) in HH increased the response to fMLP by around twenty 
fold, and so this was added prior to stimulation; i.e. the PMN were primed before 
activation (1.5.2.). Where several antagonists were to be assayed simultaneously PMA 
was used as the agonist as the respiratory burst is prolonged, and so the computer has a 
chance to record all the data. Where fMLP was used as the agonist, the response was 
too rapid to use more than three antagonists simultaneously.
'
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2 .7 .  Degranulation Assays
For these assays, neutrophils incubated at 37®C in FIO were exposed to agonist for 
twenty minutes before the cells were primed with 1 |ig/ml w/v cytochalasin B (Sigma) 
in HH for a further five minutes. The cells were then challenged for ten minutes with 
10'^ M fMLP (Sigma) before centrifugation (5 minutes at 2000 rpm). The supernatant 
was aspirated and stored on ice until use.
2 .7 .1 .  Primary Vesicles
Elastase assays were essentially as described by Jan off (1969). 6mg N-t-BOC- L 
alanine p-nitrophenol ester (Sigma) was dissolved in 1ml acetonitrile and made up to 
100ml in 50mM sodium phosphate buffer, pH 6.5. The change in absorbence at 347.5 
nm was recorded using a Shimadzu UV-180 spectrophotometer over a three minute 
period. The results were plotted and the gradient of the line was used to approximate 
the relative amount of active elastase released. This was calibrated using porcine 
pancreatic elastase (ICN Flow).
As a control, myeloperoxidase (MPO) was assayed as per McRipley and Sbarra 
(1967). Guaiacol (Sigma) 20mM was freshly made up in water and added to sodium 
phosphate buffer (lOmM, pH 7.0). lOOpl of supernatant was added to a 3ml cuvette 
and activated with the addition of 20|al IM H2O2. The method for quantitating release 
of active MPO was the same as for elastase, however the wavelength used was 470nm.
2 .7 .2 .  Secondary Vesicles
Collagenase activity was measured using gel electrophoresis of soluble type I collagen 
(2mg / ml) (Fluka) products following a fifteen hour incubation with the cell 
supernatant (described in section 2.7.) in the presence of Tris buffer (50mM Tris/ HCl 
pH 7.5, 5mM CaCL, 0.2M NaCl) essentially as per Aaku et al., 1990 and Michaelis et 
ah, 1992. 0.5mM Aminophenyl mercuric acetate (Sigma) was added to activate any 
collagenase present in the supernatant, and PMSF and anti-trypsin were used to
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inactivate serine proteases. Samples were mixed 1:1 with boiling mix and run on 7.5% 
polyacrylamide gels. Gels were analysed visually for differences in bands.
Plasminogen activator release (essentially as per Leigh, 1993) from specific granules 
was used as a back-up for collagenase release, and relies on the clearing of a casein gel 
(powdered milk). Gels used were 1cm thick, comprising 1% agarose (Gibco) and 1% 
skimmed milk powder in 50mM Tris-HCl pH 8.1, 150 mM NaCl. The gels were 
allowed to set and wells of 1/8 inch diameter were cut. Cell supernatants were added to 
the wells and incubated at 37®C overnight. The diameters of the cleared area around the 
wells were measured, with each assay being performed in triplicate.
2 .7 .3 .  Secretory Vesicles
Alkaline phosphatase was assayed as per DeChatelet & Cooper (1970), with the 
conversion of p-nitrophenyl phosphate being recorded at 410nm. PMN (lOV ml) were 
incubated as described in 2.7. with the exception that instead of centrifuging the 
sample, three volumes of ice cold FIO was added to stop the reaction. 0.5ml PMN 
suspension was mixed with 0.5ml p-Nitrophenyl Phosphate (2mg/ml aqueous) and 
0.5ml aminomethyl propanol (O.IM, ImM MgC12, pH 10). This was incubated at 
37°C for 30 minutes and terminated with 10ml 20mM NaOH. The absorbence at 
410nm was recorded using a sample containing a pre-terminated blank (i.e. NaOH was 
added before the PMN).
2 .8 .  Viability Testing
. . I
Release of the cytosolic enzyme Lactate Dehydrogenase (LDH) has been used as a 
sensitive method for testing cell integrity (Pesce, 1964). Cells to be tested were 
incubated in medium, removed by centrifugation, and the supernatant tested in a 
spectrophotometric LDH assay system. Each cuvette contained 3ml sodium phosphate 
buffer (lOOmM) pH 7.0, Im mole sodium pyruvate (BDH) and 0.35m mole reduced
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nicotinamide adenine di-nucleotide (NADH) (Sigma). lOOfil supernatant was added to 
each cuvette and mixed. The rate of decrease in absorbence at 340nm recorded over a 
three minute period was used as a measure of the cell integrity.
2 .9 .  UseofHPLC
2 .9 .1 .  Calibration of SMART System
Standards (Sigma) were used to produce a calibration curve of different prostaglandins 
/ leukotrienes. The areas under the curves were plotted against the concentration. Lipids 
were extracted and analysed essentially as per Chilton (1989) and Rosenthal & Franson 
(1994) with the exception that the wavelength could not be adjusted to 270 / 234nm. 
Therefore 280nm was used. The standards from Sigma appeared to be monitored 
correctly; i.e. all of the peaks were in the coiTect relationship to each other.
2 .9 .2 .  Prostaglandin Release
The release of arachidonic acid metabolites was assayed using a methanol gradient on a 
SMART system HPLC (Pharmacia). 5pg Prostaglandin (Sigma) was added to each 
supernatant and acidified with 10% formic acid. Lipids were extracted into ethyl 
acetate. This was vacuum dried and dissolved in buffer A (55% methanol, 44.5% H2O, 
0.5% phosphoric acid). The column was allowed to equilibrate for 6 minutes before the 
buffer was changed to 100% buffer B (100% methanol) over 35 minutes (Chilton, 
1989).
2 .9 .3 .  Purification of STMS
The purification strategies for STMS are summarised in fig 3.
Starting material was force dialysed using type I dialysis tubing, sterility being 
maintained by autoclaving all glassware and tubing before starting. The retained 
material was applied to a monoQ column and eluted using a salt gradient. The fractions 
that were active for dispersive motility were pooled and applied to a Pharmacia peptide 
column (gel filtration 0.1 to 7kD range). The large molecules not inhibited by the
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column were pHed to 2 and applied to reverse phase where any small molecules held 
by ionic bonds would be released. It was noted that one such molecule was released. 
This molecule coincided with a small molecule from the peptide column which was 
applied to reverse phase chromatography also.
I
The material that passed through the dialysis tubing was freeze dried and fractionated 
with P2 (Bio-Rad) using 150mM NaCl as eluent. The fractions in the size range of 
lkD-2kD (including vitamin B12) were pooled and applied to reverse phase column. 
The activity eluted at approximately 55% buffer B (50% acetonitrile, 0.12% TFA), with 
the active fractions being subjected to a second reverse phase separation.
Previously, STMS had been purified using other techniques. These included the freeze 
drying of the starting material and applying the concentrated sample to P2 (Bio-Rad) 
using 150mM NaCl. The fractions that produced dispersive motility were pooled, 
freeze dried again and applied to reverse phase HPLC. The active fractions were 
pooled, and applied to gel filtration (Pharmacia peptide column) in an attempt to 
separate the active molecule from the contaminating material.
2 .1 0 . Inhibition of Phagocytosis
To determine if there were any effects on the ability of neutrophils to phagocytose, latex 
beads (Sigma) at a final dilution of 1:10,000 were added to the neutrophils for 30 
minutes, before fixing with 1% paraformaldehyde (Sigma), washing and counting the 
number of beads phagocytosed per neutrophil. Wojiak and Cross an (1993) used 
fluorescent latex beads for this assay counting the beads under fluorescence optics but, 
surprisingly, this was not found to be necessary, although using fluorescent optics did 
make the beads more immediately visible.
II
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Fig. 3 Schematic diagram of purification strategies employed with 
STMS
Purification X. Purification Y.
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2 .1 1 . Tracking assay
The assay used chambers as designed by Dow et ah, (1987) where a coverslip was 
fastened to the bottom of a chamber by wax, and the resulting well coated with 1% 
BSA solution for 20 minutes before washing with saline and addition of PMN at a 
concentration of 10  ^per ml. These were allowed to adhere for 15-20 minutes before 
washing with saline. The negative control was always checked at this stage to ensure 
that the quantity of cells was adequate for tracking. If there were too many cells, then 
they chambers required to be washed more vigorously before use. If there were too few 
PMN, then the chambers were left for a further 5 minutes before washing (and the 
above procedure used to determine the cell number. If at that point there were too few 
cells, then the washing stage was reduced). The well was filled with substrate (around 
400ju.l) and the chamber closed with a second coverslip and sealed with wax.
The microscope used was a Leitz inverted phase contrast microscope fitted with a stage 
micrometer and thermostated chamber. This allowed a stable temperature to be 
maintained throughout the experiments, and for the stage incubation chamber to be 
open for the shortest time possible whilst appropriate fields of cells were selected.
For experiments with a tilted stage, the microscope was tilted to an angle of 30° , where 
is was held throughout the course of the experiment.
2 .1 1 .1 . Tracking procedure
The assay chamber was put on to the stage, and the field displayed on the real time 
monitor. When the tracking program was started, a frame was taken and the cells 
displayed in 16 grey levels, the threshold was pre-set at a level where most motile cells 
(phase bright) could be tracked. Islands above this level were outlined in red, but those 
below a threshold area were discarded. In the first frame, the computer stored the centre 
co-ordinates of all of the selected cells. In subsequent frames, this procedure was 
repeated but the centre positions of the cells were joined to the previously determined
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centres thus displaying the continuous track for each cell. This meant that the observer 
could compare the real time behaviour of the cells with the tracking procedure to check 
whether the cells were being correctly identified.
The slope of the linear portion of the plot of the difference between the square of the 
mean displacement of the cell population and the square of the drift was measured by an 
on-screen line drawing program, the slope of this line was used as the diffusion co­
efficient, and the intercept on the time axis was the persistence of locomotion.
59
IThe tracking data was displayed as:1) instantaneous speed, i.e. the average distance covered by all cells in one frame,
2) the number of cells still being tracked,
3) the mean displacement of the cell population.
4) the net displacement of the cell population from the origin (drift).
5) the difference between the mean displacement of the population and the drift,
6) the square of the mean displacement of the cell population,
7) the square of the drift,
8) the difference between the square of the mean displacement of the cell population and 
the square of the drift.
2 .1 1 .2 .  Data processing *5;
I
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3 .1 .  Remit of work done
Despite work carried out on this project to date a number of important points have yet to 
be resolved. These include answers to the questions:
Is STMS a single factor, or more than one factor acting in synergy?
Is the observed activity independent of the ionic composition of the extract?
Is the synthesis of STMS stimulated by steroids 
Is the release stimulated by steroids?
Is the release simply a result of cell death
Is STMS a mediator of steroid anti-inflammatory action.
3 . 2 .  STMS - Overview
This work was carried out as part of a joint project where the main aim was the 
purification and chemical characterisation of the factor(s) responsible for STMS 
activity. The first phase was to identify the spectram of activities present in the starting 
culture supernatant and to determine which of these activities co-purified with the 
dispersive motility (Chettibi et al, 1994b). The initial problem with handling STMS 
concerned the apparent size of the molecule. Techniques available for measuring size 
included gel filtration and force dialysis. When STMS was handled at low salt 
concentration, the active species appeared to be partially retained by a dialysis 
membrane. In consequence, dialysis appeared to split the activity into two roughly 
equal portions. When it was partially purified, and handled at low salt concentration, 
the activity was eluted with the electrolyte peak on gel filtration. This gave the model 
that the active species was a small molecule normally bound to a protein, but when 
released from this protein, interacted strongly with the gel filtration matrix. Hence there 
was no easy way to desalt STMS, or to change the ionic composition of the initial 
extract. To a large extent this problem was resolved by the observation of J. Young that 
purified STMS was active at much higher dilution than crude STMS (personal
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communication), from this he deduced that the activity passing through the dialysis 
membrane was very much less in real terms than the retained activity, although the 
measured activity appeared to be very similai*.
Other components of STMS
I
;;I
1
4
The stages of purification of STMS are given in Fig.3 Most of the work was performed 
using the purification strategy X.
3
The most noticeable action of steroids on cells of the immune system is inhibition of 
protein synthesis. This was borne out by comparison of STMS and CMS on SDS- 
PAGE. The former has very few bands, whilst the latter has a complex band pattern 
(A. Lawrence, personal communication). One of the problems of the incubation 
procedure is that proteolytic activity cannot be effectively inhibited because protease 
inhibitors tend to be toxic to cells. Thus degradation is certain to occur because these 
cells secrete proteolytic enzymes. However it is also known that steroids inhibit the 
release of proteolytic enzymes (see below) and therefore proteolytic activity should be 
much less prevalent in STMS compared with CMS. The best evidence for the presence 
of proteases in these extracts comes from characterisation of some of the molecular 
species found in STMS / CMS. IL-8 and thymosin p4 are present in STMS indicating 
that trypsin-like protease activity is minimal. However, one small peptide purified from 
STMS was unambiguously characterised by Edman degradation as a proteolytic 
fragment from actin generated by cleavage of an V-P bond and a Q-G bond, leaving 
PSIVGRPRHQ (G. Kemp, personal communication). It is of interest that this fragment 
is one of the postulated thymosin p4 binding sites on actin (Safer et al., 1997). 
Throughout the purification by strategy X vitamin B12 co-purified with the active 
fractions. The reverse phase step succeeded in separating the activity from native 
vitamin B 12 but not from (a very minor component of vitamin B 12) acyano Vitamin 
B12 (D. Pappin, personal communication).
'3
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Physico-chemical properties of STMS
STMS does not appear to be highly hydrophobic, as it elutes early from reverse phase 
HPLC and it does not absorb on to phenyl sepharose. The activity is not retained by 
concanavalin A sepharose indicating that it is unlikely to contain oligosaccharide. It is 
clearly small with a molecular weight between 1 and 5 kD. The activity will be 
absorbed strongly by gel filtration media, indicating a high degree of polarity.
STMS differs from all other known factors which stimulate neutrophil migration in that 
it gives persistent locomotion at a uniform concentration. One aim of this work was to 
obtain a model for persistence which could apply to loosely adherent cells in which 
locomotion was clearly discontinuous, and this required a detailed determination of the 
shapes of the cells, and the mode of attachment to the substrate.
STMS from monocytes
As stated above, monocytes were allowed to adhere to tissue culture plastic in the 
presence of serum, and then cultured in serum free medium. This facilitated the 
purification of the supernatant which would otherwise be an extremely protein rich 
solution. Previous work had shown that the yield of STMS activity was comparable in 
the presence or absence of serum. Monocytes cultured in this way for 24 hours 
produced supernatant with STMS properties, but no detectable activity was produced 
after the culture supernatant was replaced with fresh serum free media for a further 24 
hours. Those monocytes that remained adhered to the plastic looked no different after 
this second incubation, but many of the monocytes had become detached from the 
plastic (approx. 30%). To test if the STMS-like activity could be produced 
continuously, these experiments should be performed in a complete medium with 
aliquots removed at intervals of perhaps 12 hours. This would be a useful diagnostic
62
■_________________      Results
î|
test of the ability of monocytes to produce the factor indefinitely, but would not have 
been particularly helpful as the purification of media containing semm would increase 
the difficulties presented several fold. This would also be the case for purification 
strategy Y, as serum contains many molecules that would not be removed by dialysis, 
and could prevent efficient running of columns. Equally, purification strategy X would
:retain the small molecules present in serum in the P2 column.
STMS from other cell sources
3 . 3 ,  Observations of the properties of STMS treated cells
Culture of Endothelial cells or neutrophils with dexamethasone do not produce STMS- 
like activity in the supernatant. Platelets have been lysed, but again the supernatant did 
not show any STMS-like activity (results not shown). Macrophage-like cell lines did 
produce some activity when cultured in the presence of dexamethasone, but to a lesser 
extent than monocytes in culture. These cells were cultured further in the presence of 
serum to allow growth to continue, and the culture process repeated. Considerably less 
STMS-like activity was produced in this subsequent culture (as assayed by tracking 
experiments). This indicated that STMS-like activity was something that cells produced 
once, but were incapable of continuing to produce (result not shown). The reasons for 
this remain unexplained, but are consistent with the earlier work, where STMS-like 
activity was only produced once from monocytes (J. Young, personal communication).
When cells were added to the tracking chambers, they were initially rounded. During 
the next five minutes they became increasingly blackened (phase dark) as if they were 
spreading out and becoming very much thinner. However, over the next twenty or so 
minutes they tended to return from this phase black state to a phase bright condition 
where they were highly motile. During the first hour of tracking, the speed and the 
persistence increased. This was in contrast to the CMS treated cells which also turned
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phase black initially, but did not return readily from this state, and as such were 
difficult to track. There was no persistence from CMS treated cells. It was noted that 
other agonists commonly used to stimulate PMN motility, e.g. fMLP also induced the 
cells to blacken initially, return from this condition to be tracked, but did not maintain 
their speed of locomotion for more than half an hour under these conditions. STMS 
treated PMN moved in an unusual manner, that was distinctive of STMS treatment. The 
migration of an individual cell appeared to be a discontinuous process. For most of the 
time, the cell appeared to be stuck by a tail to the substrate and appeared to undergo a 
tethered exploration in any direction. The cell body would extend out from the anchor 
and eventually the tail would follow the leading edge. Translocation of the tail tended to 
occur as a rather sudden movement, leading to a suggestion that the motility is based on 
a looping model (somewhat similar to how a catei'pillar travels). An individual cell 
appeared to migrate in a series of jumps across the screen, inconsistent with the model 
that direction was determined by inertia. Cells migrated in a stochastic manner where 
once extending a leading edge, they continued to do so until the tail became detached.
The tail of the cell either retracted back into the cell body, or was propelled over the top 
of the PMN body, but normally at a shallow angle and the locomotory step repeated. It 
has not yet been resolved if the motility is by the caterpillar walk, or by a tumbling end 
over end. The fast step was the movement of the tail up to the cell body; the rate 
limiting step therefore appears to be the exploratory movement of the body of the cell.
%3 . 3 . 2 .  Tilt assays
Because the locomotion of these cells is highly dispersive, the calculation of the 
apparent diffusion coefficient depends strongly on population displacement. If all of the 
cells have a component of movement in a single direction, this will give it a 
disproportional effect in calculating net displacement. Thus it was very important to 
allow for any component of drift in the system. The initial tracking assay displays drift 
per frame as a vector and it was frequently noticed that the drift vector tended to point in
Results
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the same direction. Possible explanations for this were temperature gradients being 
formed by the heater, or gravitational force caused by an unlevel stage. To check 
whether this last factor made a significant contribution, tracking assays were carried out 
with the microscope tilted at approximately 30 degrees. The results of this were quite 
dramatic. For fMLP treated cells, there was virtually no difference between the 
migration of cells on a flat or on a tilted stage. For STMS treated cells, in contrast, the 
migration was extremely strongly polarised down the slope. Nevertheless, our 
observations showed that the cells were not free floating. The tracking assay was set a 
search limitation of lOjum radius per 5 sec frame. Cells moving faster than this were 
lost. Free floating cells were observed and in all cases, they were not tracked, but the 
majority of cells migrated at a speed considerably more than cells on the untilted stage, 
but clearly not the speed of cells in free fall (fig. 4.). In these cells, the rate limiting step 
was the detachment of the cell tail, with the exploratory phase apparently being very 
much faster than in experiments where the stage was level. This highly polar 
moiphology was particularly distinctive in starting material, perhaps less so in later 
purifications. S
3 . 4 .  Electron Microscopy
3 . 4 . 1 .  PMN Treated in Suspension
PMN when viewed under SEM have a characteristic moiphology. Untreated (control) 
cells are commonly spherical with very few if any protrusions, although there are 
obvious folds of membrane on the surface (fig. 5). These folds may be capable of 
allowing the cells to increase their surface to volume ratio dramatically in the absence of 
any translocation of new membrane to the surface. As noted above (2.5) there can be a 
noticeable shrinkage of the cells during preparation. However, as all treatments were 
prepared in the same manner, no appreciable differences in size should occur, and so 
can be discounted from being a source of error within these assays. Treatment of 
PMNs in suspension with fMLP (10~^M) showed that cells retained a rounded body
F:4
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consistent with phase brightness, with some of the ridges observed on the control cell 
extending well beyond the cell body, with an appearance expected for actively ruffled 
membrane (fig. 6). Similarly, treatment with IL-8 gave an extremely irregular and 
rough surface morphology with numerous, highly distorted projections (fig. 7).
7
Ie
66
Results
Neutrophils were allowed to adhere to BSA coated coversiips in wells as described in 
materials and methods. The wells were washed, filled with test substrate and sealed. 
The chambers were incubated at 37°C for twenty minutes before tracking was 
commenced. fMLP cells were observed to continue to track as normal, with very little 
diffusion away from the starting point. STMS treated cells however, were observed to 
migrate down-stage.
Upper image, STMS treatment 
Lower image, fMLP treatment
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Fig. 4a. Screen images from tracking experiments with a tilted stage, showing 
tracks of fMLP and STMS treated neutrophils.
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The data compiled by the computer shows that fMLP treated PMNs are not effected by 
drift, whereas almost the entire motility induced by STMS treatment is due to drift. As 
the overall drift is subtracted from the speed of the PMNs, then the figure measured by 
the computer is erroneous. The speed has to be corrected to allow for this drift (5.8|itn 
per minute), giving a speed comparable to fMLP treatment.
The microscope stage was measured to be at an angle of 3CP.
Upper image, STMS treatment 
Lower image, fMLP treatment
Results
Fig. 4b. Screen images from tracking experiments with a tilted stage showing data 
gathered from STMS and fMLP treated neutrophils.
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Fig 5. Scanning Electron Microscope image of Hams F10 treated neutrophils
Neutrophils were treated in suspension with Hams FIG for thirty minutes and prepared 
for scanning electron microscopy. Magnification 6,400; scale bars are 1p.m.
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fig 6 Scanning Electron Microscope image of fMLP treated neutrophils
Neutrophils were treated in suspension with lO'^M fMLP for thirty minutes and 
prepared for scanning electron microscopy as described in materials and methods. 
(Magnification 6,400)
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Fig. 7 Scanning electron microscope image of an IL-8 treated neutrophil
Neutrophils were incubated with IL-8 (1 P-g/ml) for thirty minutes before preparation 
for scanning electron microscopy. Magnification 6,400; scale bars l|im.
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Cells treated with CMS were very flattened consistent with the phase black projections 
(fig. 8). In marked contrast, cells treated with STMS were elongated. Although 
membrane folds were present, the surfaces were extremely smooth. The appearance 
was sufficiently characteristic to allow STMS treated cells to be identified from the 
SEM alone. The cells have a prominent tail, which is connected to the elongated cell 
body by a thinner region. The end distal from the tail appear to have weak lamella- 
forming activity (fig. 9). The inference from these results is that cells are bipolar with 
one end being dominant, and morphologically different from the rest of the cell body. 
The narrow neck of the cell could well have acted act somewhat like a hinge in the tilt 
assays, with the tail being the point of firm adhesion, dexamethasone treated control 
PMNs were virtually indistinguishable from control PMN treated with F 10 medium. 
Stevenson observed that colchicine caused PMN to disperse from a cell pellet in a 
manner similar to PMS (STMS), and so it was of interest to examine the effects of 
colchicine (lO'^M) treatment of PMN to determine if migration pattern could be linked 
to cell shape. However, PMNs in suspension treated with colchicine were radically 
different in shape from PMN treated with STMS (crude) under the same conditions, 
producing drastic changes in the appearance of cells when treated in suspension. 
Copious ruffles were observed on the surface (fig. 10), though these were not as deep 
nor as prominent as those produced in response to fMLP treatment. Furthermore, 
widespread projections over part of the surface, give it a roughened appearance not 
produced by STMS. This was evident from comparing STMS treated samples with the 
smooth surface, uniform bipolarity with only occasional projection(s), whereas with 
colchicine samples the most common feature was a single projection from a rounded 
cell body with copious ruffles over other parts of the surface. This contrasts with the 
effects of colchicine on fibroblasts, where the cells become rounded, and considerably 
smaller in size (Gail & Boone, 1971). There is no evidence to suggest that this single 
projection is a persistent feature that could account for persistent locomotion of the cell.
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Fig 8 Scanning Electron Microscope image of a CMS treated neutrophil
Neutrophils were treated in suspension with CMS for thirty minutes and prepared for 
scanning electron microscopy. Scale bars are Ifim; magnification 6,400.
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Fig. 9 Scanning electron microscope image of STMS (crude) treated neutrophils
Neutrophils were treated with STMS (crude) in suspension for thirty minutes before 
preparation for scanning electron microscopy. The dried filters were shaken on to 
double sided tape coated stubs and coated with gold as described in materials and 
methods. Magnification 6,400
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Fig. 10 Scanning electron microscope image of Colchicine treated neutrophil
Neutrophils were treated with colchicine (Kh-^M) in suspension before preparing for 
scanning electron microscopy.
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A possible interpretation of the morphology of STMS treated cells is that polarisation of 
cells by STMS is not accompanied by degranulation, so that no excess membrane is 
brought to the surface. This would account for the unparalleled smooth appearance of 
the membranes.
3 .4 .2 .  PMN Seeded on to Endothelial Monolayers
Endothelial cell sheets (cultured without steroid for 1-2 days) normally show small but 
perceptible gaps between individual cells. When these sheets were seeded with 
untreated PMNs (fig. 10) the PMNs remained rounded, but were normally found in 
association with endothelial cell junctions. When PMNs seeded on to the endothelial 
cell sheet were subsequently treated with fMLP (lO'^M) the appearance of the surface 
was virtually unchanged, although fewer cells were found in non-junction regions. The 
reduced visible bulk of the cell indicated that active transmigration was taking place, 
and these cells had a relatively smooth upper surface. fMLP treatment of PMNs in 
association with the endothelial cell sheet caused a visible increase in the number of 
gaps between the endothelial cells, with many of the PMNs migrating through these 
gaps (fig. 12). The moi*phoiogies of the PMNs not associated with endothelial cell 
junctions were characterised by a relatively smooth surface and a definite leading front, 
this being very similar to that described by Bakowski and Tschesche (1992). STMS 
treatment of PMNs already seeded on to endothelial monolayers produced the same 
general effect, but PMNs had a noticeably smoother surface, and there was very little 
evidence that any of them were trans-migrating through the endothelial cell gap. 
Conversely STMS cells appear to continue to migrate across the surface of the 
endothelium (fig. 13). PMNs treated with STMS and then seeded on to the endothelial 
surface were found predominantly over the gaps between the endothelial cells, but there 
was no evidence that they were engaged in migration through the gap (result not 
shown). These gaps between cells are not anticipated to be due to the drying stages, as 
freeze-drying was used. This method of drying does not induce as high a level of
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Fig. 11 Scanning electron microscope image of a FIO treated neutrophil adherent to 
endothelium.
Bovine aorta endothelium was grown to confluency in the absence of dexamethasone. 
The monolayer was washed and seeded with neutrophils which were allowed to adhere 
at 37°C for twenty minutes before washing and incubating in FIO at 37°C for thirty 
minutes before preparation for scanning electron microscopy. Magnification 6,400; 
scale bars are l|xm.
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Fig. 12. Scanning electron microscope image of an fMLP treated neutrophil seeded 
on to bovine aorta endothelium.
Neutrophils were seeded on to bovine aorta endothelial cells (which had been grown in 
the absence of dexamethasone) for twenty minutes and then washed. fMLP (lO’^ M) 
was then added and the cells incubated at 37°C for a further thirty minutes before 
preparation for scanning electron microscopy as described in materials and methods. 
Magnification 3,200, scale bars are l|im.
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Fig. 13 Scanning electron microscope image of an STMS treated neutrophil on 
bovine aorta endothelium.
Neutrophils were seeded on to endothelial monolayers which had been grown in the 
absence of dexamethasone and allowed to adhere for twenty minutes before washing 
and incubated in STMS for a further thirty minutes at 37®C before preparation for 
scnnning electron microscopy as described in materials and methods. Magnification 
3,200, scale bars are 1p.m. '
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Fig. 14 Scanning electron microscope image of neutrophils seeded on to bovine 
aorta endothelium before treatment with IL-8.
Neutrophils were seeded on to bovine aorta endothelial cells (which had been cultured 
to confluency in the absence of dexamethasone) and allowed to adhere for twenty 
minutes at 37°C before washing and then incubated in the presence of IL-8 (1 |ig/ml) 
for a further thirty minutes before preparation for scanning electron microscopy. 
Magnification 1,600, scale bars 5p.m.
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Fig. 15 Scanning electron microscope image of colchicine treated neutrophils 
adherent to bovine aorta endothelium.
Neutrophils were seeded on to bovine aorta endothelium (which had been cultured in 
the absence of dexamethasone) for twenty minutes before washing. Colchicine (lO’^ M) 
was then added to the cells and the incubation was resumed for a further thirty minutes 
before the coverslips were prepared for scanning electron microscopy as described in 
materials and methods. Magnification 6,400, scale bars IjLim.
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shrinkage (compared with critical phase drying) and so the size of the gaps is less likely 
to be exaggerated during the drying stage.
Neutrophils treated with IL-8 when adhered to endothelial cells, have a very high 
degree of homotypic aggregation (fig. 14), with those cells not aggregated appearing 
very similar to fMLP treatment. Colchicine treatment of PMNs produced very deep 
ruffles over much of the surface of the cell (fig. 15), and also apparently a slight 
decrease in the size of the cell (not shown), in line with reports by Gail and Boone
(1971), but conflicting with Lackie (1974).
3.4.2.I. Steroid Treatment of Endothelium
Endothelial cell sheets (cultured for 1-2 days) in the presence of steroids normally show 
considerably fewer gaps between the individual endothelial cells. PMN seeded on to 
monolayers and then treated with fMLP were predominantly found in the endothelial 
junction regions, and these PMNs did not possess a leading edge (fig. 16). The PMNs 
however did not transmigrate to the same degree as they did on non-steroid treated 
endothelium. This was observed also with IL-8 treatment of the neutrophils (fig. 17).
As expected from results with non-steroid treated endothelia, STMS PMNs showed 
virtually undetectable transmigration activity (fig. 18).
The size of neutrophils as observed by SEM has to be used as a guide between 
treatments, and not as a measurement of the size of cells. This is because all cells shrink 
when dried by critical point drying, and it is known that microtubule based structures 
are more resistant to shrinkage than microfilament based structures (L. Tetley, personal 
communication). It was therefore of interest that the extreme morphologies displayed 
by colchicine treated PMNs were maintained in the virtual absence of microtubules, 
where susceptibility to collapse should be greatest.
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Fig. 16 Scanning electron microscope image of an fMLP treated neutrophil on 
dexamethasone treated endothelium.
¥
Neutrophils were seeded on to bovine aorta endothelium (which had been cultured to 
confluency in the presence of 10‘^ M dexamethasone) and allowed to adhere for twenty 
minutes before washing. The coverslips were then incubated in fMLP (10‘^ M) at 37^C 
for a further thirty minutes and prepared for scanning electron microscopy as described 
in materials and methods. Magnification 3,200; scale bars l|Lim.
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Fig. 17 Scanning electron microscope image of an IL-8 treated neutrophil adhered 
to dexamethasone treated bovine aorta endothelium.
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Neutrophils were seeded on to bovine aorta endothelial monolayer (which had been 
grown to confluency in the presence of 10-^M dexamethasone) and allowed to adhere 
for twenty minutes before washing and IL-8 ( 1 |ig/ml) added. The cells were incubated 
at 37°C for a further thirty minutes before preparation for scanning electron microscopy 
as described in materials and methods.
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Fig. 18 Scanning electron microscope image of STMS treated neutrophils adherent 
to bovine endothelium
Bovine aorta endothelial cells were grown to confluency in the presence of 10‘^M 
dexamethasone. The monolayers were incubated overnight in medium which had not 
been supplemented with dexamethasone and washed. Neutrophils were seeded on to 
coverslips and allowed to adhere for twenty minutes before washing. The coverslips 
were then incubated with STMS for thirty minutes at 37®C before preparation for 
scanning electron microscopy as described in materials and methods. Magnification 
3200, scale bars 1pm.
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3 .5 .  Confocal Microscopy
3 .5 .1 .  Staining of polymerised actin
86
Z-series taken from confocal laser microscopy of PMN on BSA coated coverslips 
reveals very distinct differences between cells treated with various agonists, but in 
particular it revealed a highly unusual distribution in STMS treated cells.
Control (Ham's F-10) treated cells are rounded and have a patchy distribution of 
polymerised actin throughout the cell, the patches being randomly distributed and 
varying in size, but in most cases are close to the cell surface (fig. 19). There is a 
tendency for cells to have 2-3 larger patches of denser staining. Watts and colleagues 
(1991) have proposed that denser foci of polymerised actin act as sites where 
pseudopod formation may be initiated, and here the PMN on the left of the field appears 
to be initiating a pseudopod from such an actin concentration.
fMLP treated PMN (fig. 20) were characterised by a much greater density of 
polymerised actin which was often concentrated into regions within the cell body, and 
by large, branched pseudopods containing more diffuse polymerised actin.
IL-8 treated PMNs commonly had very dense areas of polymerised actin associated 
with psuedopodia (fig. 21), with a definite polarity set up. However, this polarity is 
clearly different from that induced by STMS treatments. The extension and branching 
of the pseudopodia indicate a large degree of polymerised actin in both of the opposing 
poles of the PMNs.
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Fig. 19 Confocal Microscopy image of neutrophils treated with FIO, stained with 
TRTTC Phalloidin
Neutrophils were allowed to adhere to BSA coated coverslips for twenty minutes 
before washing and incubation in Hams FIO for a further 30 minutes at 37®C before 
fixation with 1% paraformaldehyde and preparation for fluorescence microscopy as 
described in materials and methods. Magnification xlOO.
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Fig. 20 Confocal microscopy image of neutrophils treated with fMLP (lO'^M), 
stained with TRTTC Phalloidin.
Neutrophils were allowed to adhere to BSA coated coverslips for twenty minutes and 
washed before incubation with lO ^M fMLP at 31^C for a further thirty minutes before 
fixation in 1% paraformaldehyde and preparation for fluorescence microscopy as 
described in materials and methods. Magnification xlOO.
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Fig. 21 Confocal microscopy image of adherent neutrophil treated with IL-8, 
stained with TRTTC Phalloidin.
Neutrophils were allowed to adhere to BSA coated coverslips for twenty minutes 
before washing and incubation with IL-8 (1 |ig/ml) for thirty minutes at 37°C. The 
cells were fixed with 1% paraformaldehyde and stained for F-actin as described in 
materials and methods. Magnification xlOO.
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Regions of polymerised actin are characteristic of focal adhesions in other cell types, 
and so it is not unrealistic to assume that these represent adhesion sites in the present
90
CMS treated PMNs tended to have more foci of condensed actin (fig. 22), but not as 
strongly associated with pseudopodia which were themselves smaller and less branched 
than those on fMLP treated PMN.
TNF-a treated PMNs were characterised by having numerous foci of relatively diffuse 
actin staining, with very few pseudopodia observed (fig. 23). There also tended to be a 
larger focus of actin towards the periphery of the PMN.
STMS treatment of PMN gave a visibly distinct image from any other agonist tested. 
The bipolar cells displayed one major actin concentration at the narrower of the two 
poles with a much lower concentration at the opposite pole, and little found anywhere 
else (fig. 24). The closest resemblance was to IL-8 treated PMNs, but other aspects of 
the morphology were quite distinct and in particular the long spikes apparent in IL-8 
treated cells were absent in STMS treated PMN.
case. The results are consistent with the visual observation that PMNs treated with IL- 
8, TNF-a, fMLP etc. have multiple adhesion sites, whilst cells treated with STMS 
behave as if they had only one point of attachment.
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Fig. 22 Confocal microscopy image of adherent neutrophils treated with CMS, 
stained with TRTTC Phalloidin.
Neutrophils were seeded on to BSA coated coverslips and allowed to adhere for twenty 
minutes before washing and incubation with crude CMS for thirty minutes at 37°C 
before fixation with 1% paraformaldehyde and staining of F-actin using TRITC 
Phalloidin as described in materials and methods. Magnification xlOO.
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Fig. 23 Confocal microscopy image 
with TRTTC Phalloidin
of TNF-a treated adherent neutrophils, stained
Neutrophils were allowed to adhere to BSA coated coverslips for twenty minutes and 
washed with saline before incubation with TNFa (8 xl03 units/ ml) for thirty minutes. 
The cells were fixed with 1% paraformaldehyde and stained for F-actin as described m 
materials and methods. Magnification x 100.
92
Results
Fig. 24 Confocal microscopy image of adherent neutrophils treated with STMS , 
stained with TRTTC Phalloidin.
Neutrophils were allowed to adhere to BSA coated coverslips for twenty minutes 
before washing and incubation with crude STMS at 37®C for thirty minutes before 
fixation with 1% paraformaldehyde and preparation for fluorescence microscopy as 
described in materials and methods. Magnification xlOO.
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Results
Fig. 24 Confocal microscopy image of adherent neutrophils treated with STMS , 
stained with TRTTC Phalloidin.
/
Neutrophils were allowed to adhere to BSA coated coverslips for twenty minutes 
before washing and incubation with crude STMS at 37®C for thirty minutes before 
fixation with 1% paraformaldehyde and preparation for fluorescence microscopy as 
described in materials and methods. Magnification xlOO.
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3 .6 .  The effect of STMS on Adhesion of PMNs
3.6.1. Adhesion to Protein Coated Glass
Crude STMS was reported to reduce the adhesion of PMNs on protein coated glass 
(Chettibi et al., 1993). However, this work was repeated several times and it became 
clear that STMS treatment of PMNs increased the basal levels of adhesion to BSA 
coated glass, but not as much as fMLP (IQ-^M) nor CMS treatment. It is possible that 
the presence of IL-8 in crude STMS may account for this increase. In contrast, partially 
purified STMS (fig 2. stage 2 and stage 3) decreased adhesion by around 40% (not 
shown). The true effects of STMS are perhaps better shown when it is used to counter 
fMLP induced adhesion, reducing the adhesion by 20% (fig. 25).
3 .6 .2 .  Adhesion to endothelial cells
Preliminary tests showed that the adhesives of PMNs to untreated endothelial cells was 
very low, and in order to test the effect of STMS in this system the endothelial cell 
sheet was pre-activated by a number of agonists known to increase its adhesives 
(Gamble et al., 1985; Lorant et al., 1991). These included various cytokines (IL-1(3, 
TNF-a, Thrombin) and in the procedure adopted, the endothelial cells were incubated 
with an optimal level of IL-lp for either 4 or 24 hours before addition of PMN. This 
pre-incubation increased the basal level of adhesion by 600% (fig 26).
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Fig. 25 STMS reduction of fMLP induced adhesion of neutrophils to protein coated 
glass
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Neutrophils were seeded on to BSA coated glass, and allowed to adhere for twenty 
minutes before washing and incubating at 37°C for thirty minutes. The coverslips were 
washed and the specific radioactivity quantitated as described in materials and methods.
Statistical analysis (Student's T-test) showed that fMLP treatment followed by STMS
treatment significantly lowered the adhesion of the PMN to the BSA coated glass. Also,
fMLP treatment after STMS treatment significantly increased the adhesion of PMNs.
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Fig. 26 Increase in basal adhesion of neutrophils to HUVEC pre-treated with 
cytokines
Treatment Average Percentage of FIO control
FIG 33 100
ELl-p 60 182
TNFa 82 248
ILl-p and TNFa 92 279
Thrombin 60 183
HUVEC were treated for 6 hours with cytokines; IL-lp (10 units / ml) TNF (8x10^ 
units / ml) (except thrombin (2 units / ml), which requires ten minutes treatment), 
before washing and seeding of neutrophils. The coverslips were incubated for thirty 
minutes before careful washing and counting. Neutrophils were loaded with CFDA as 
described in materials in methods, and counted using fluorescence objectives (xlO).
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3.6.3. Inhibition of Adhesion to Cytokine Activated Endothelium
Results
97
Neutrophils that had been allowed to adhere for 30 minutes to endothelium pre-treated 
with ILl-P were then treated with different concentrations of highly purified STMS, or 
controls for a further 30 minutes. The effects of different treatments are shown in fig. 
27. Increasing concentrations of STMS clearly show a dose response when compared 
against the fMLP control with 10'^  and 10  ^ dilutions having significant inhibition of 
adhesion. The quantitation of STMS was based on the UV absorption at 214nm. Using 
the relationship that 1 mg/ml of protein has an A214 of 15 then it is possible to calculate 
from the UV trace the maximum concentration of peptide that could be present, making 
the assumption that STMS is a peptide, then its threshold concentration for inhibition of 
adhesion of PMNs to endothelium is about lOng/ml. During all of these assays, care 
was taken to wash all wells evenly, and with the same volume of liquid to eradicate as 
many sources of eiTor as possible. However, large error margins are inherent with this 
type of experiment, and so a number of experiments were performed using visual 
counting of cells, either under the SEM (as an after thought when visualising the 
images for 3.4.2.) or by using CFDA to visualise the cells on BSA coated coverslips. 
In all cases, ppSTMS was shown to inhibit adhesion by at least twenty percent, 
although sometimes the preparation of STMS could produce inhibition of up to almost 
one half of the FIO control.
Results
Fig. 27 Inhibition of adhesion by of neutrophils to IL-1 p pre-treated HUVEC 
ppSTMS
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(7j 10 million dilution
100 million dilution
1 billion dilution
Neutrophils were seeded on to Human Umbilical Vein Endothelial Cells which had 
been grown to confluency on coverslips and pre-treated with IL-ip. After 30 minutes, 
the coverslips were washed and different concentrations of STMS were added, and 
incubated at 37°C for thirty minutes. fMLP (lO'^M final concentration) was then added 
to the coverslips, and incubated at 37*^ C for a further twenty minutes. The specific 
radioactivity was recorded as described in the materials and methods.
* indicates statistically significant reduction in adhesion compared with fMLP control.
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3 .7 .  Degranulation Assays
3.7.1. Calibration of Elastase Assays
calibrations with every experiment.
3.7.2. Release of Elastase from Primary Vesicles
99
Porcine pancreatic elastase (ICN Flow) was used to calibrate the system used to 
determine concentrations of elastase in supernatants. Fig. 28 shows a typical reaction 
using increasing concentrations of elastase. The straight line portion of the reaction was 
used to determine the gradient of the slope. Four readings were taken for each 
concentration, and the mean gradients plotted. Due to fairly rapid deterioration of the 
substrate (over the course of 3-4 hours), it was not always possible to perform full
STMS had a dramatic effect on the inhibition of elastase release in response to fMLP 
and this was conserved throughout the purification including the high resolution reverse 
phase procedure, but has not been assayed using more highly purified material. The 
activity of the factor might therefore be followed using the inhibition of elastase release 
as an assay method. Supernatants of neutrophils primed with cytochalasin B 
(lp.g/ml)were activated with fMLP (lO'^M) having been pre-treated with varying 
concentrations of STMS. Crude STMS activated the release of primary vesicle 
contents, by at least ten percent, but as purification proceeded, the inhibitory power 
increased (fig. 29). Results were quite variable, but with certain preparations of STMS 
it was possible to inhibit the release of elastase by in excess of 90%.
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Fig. 28. Calibration of elastase using porcine pancreatic elastase
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Concentrations
Porcine pancreatic elastase was dissolved in PBS. The enzymatic activity was 
determined by adding appropriate quantities to a cuvette containing N-tBOC-l-Alanine 
p-nitrophenyl phosphate and the change in absorption at 347nm was recorded. The 
gradients were calculated and plotted.
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Fig. 29 Inhibition of release of elastase from human neutrophils pre-incubated with 
increasing concentrations of partially purified STMS
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Pre-incubation ^
Neutrophils were pre-incubated with concentrations of STMS indicated, with F 10 
(positive control) or crude cell supernatant for thirty minutes before activation of 
primary granule release. Gradients of the conversion of N-tBOC 1-alanine p-nitrophenyl 
phosphate were calculated and plotted. Significance was calculated using Student's T- 
test.
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exceptionally difficult. Unlike the assays for primary vesicle enzymes, this assay
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3.7.3. Release of Myeloperoxidase
To confirm that the effect above was due to inhibition of the release of primary vesicles 
to the surface of PMNs, the enzyme myeloperoxidase (MPO) was also assayed (fig.
30). Both assays are equally sensitive, and myeloperoxidase release closely mirrored 
that of elastase. (The lack of perfect correlation could reflect further heterogeniety of the 
vesicle population) At this stage the activity, as measured by inhibition of primary 
granule release, correlated well with the activity in the dispersive motility assays and the 
adhesion assays.
More recent purifications have produced a material which gives bell-shaped dose 
response curve when assayed for dispersive locomotion. These results were also 
observed for release of primary vesicle contents (fig. 31), where higher dilutions of 
highly purified STMS inhibited more than lower dilutions.
3.7.4. Release of Secondary Vesicles 
The use of collagenase as a marker for release of secondary vesicles proved to be
■î:
requires quantification of the cleavage of type I collagen polypeptides by SDS-PAGE.
■■The collagen bands appeared to be similar to those reported by Ohlsson (1980) and 
Sorsa et al (1985), with a  and |3 bands visible, together with low mw degradation 
products. In the assay loss of the native collagen bands is correlated with the 
appearance of the specific cleavage products, nevertheless there is considerable 
uncertainty in the identification of the bands. Despite these problems there was a clear 
indication that release of the enzyme was inhibited by STMS. However the dose 
response curve was completely unexpected in that inhibition decreased with increasing 
STMS concentration. The problem with the assay apart
___
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Fig. 30 Inhibition of release of Myeloperoxidase from neutrophils pre-incubated 
with increasing concentrations of partially purified STMS
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Neutrophils were pre-incubated with concentrations of STMS indicated, or with FIO 
(positive control) for thirty minutes before activation of primary granule release. 
Gradients of the conversion of N-tBOC 1-alanine p-nitrophenyl phosphate were 
calculated and plotted. Significance was calculated using Student's T-test.
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Fig. 31 Inhibition of release of primary granule contents using highly purified 
STMS
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Pre-incubation
Neutrophils were incubated with highly purified STMS for thirty minutes prior to 
stimulation of primary granule release. Only one assay was possible with this sample, 
and therefore statistical eiTors were not calculated.
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Fig. 32 Inhibition of collagenase release by STMS pre-treatment.
+ve, -ve, CMS, STMS, collagen, 1:20, 1:50, (not stained)
I
Neutrophils were incubated at 37®C in the presence of highly purified STMS for thirty 
minutes before activation of release of granule contents as described in materials and 
methods. The supernatants were assayed for release of collagenase (Aaku et al., 1990). 
The gel was stained by silver staining as described in materials and methods.
The unstained lane was 1; 100 dilution
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from its inherent slowness was the preliminary activation of the enzyme. Native 
collagenase is inactive, and activation requires oxidation catalysed by MPO. In vitro, 
the oxidation is carried out with amino phenyl mercuric acetate. This appeared to be 
quite variable in its effect. It is possible that success required the presence of MPO, 
hence inhibition of primary granule secretion could effect the subsequent assay of 
collagenase. Therefore the results are at best semi-quantitative.
,This result was the first indication that the action of STMS on PMNs might decrease at
.
high concentrations giving a classic bell-shaped dose response curve (fig. 32), however 
at this stage the effect was considered to be due to some artefact of the assay or to its 
inherent irreproducibility. Because of this the experiments were stopped after a few 
attempts.
3.7.5. Release of Plasminogen Activator
The assay requires measurement of areas of cleared casein in agarose gels. Untreated 
cells gave no measurable increase in the area of cleared gel. There was no statistical 
difference between different treatments of PMNs, and so it has to be stated that STMS 
did not have any effect on the release of plasminogen activator from PMN activated 
with fMLP (fig. 33).
Results
Fig. 33 Release of Alkaline phosphatase and Plasminogen factor from neutrophils 
pre-treated with STMS
Treatment Alkaline Phosphatase (units) Plasminogen 
Activator 
(mm cleared)
FIO 2.6 11.22
BSS 2.78 11
CMS 2.43 10.11
1:100 dilution 
ppSTMS
2.85 11.44
1:400 dilution 
ppSTMS
2.63 11
1:800 dilution 
ppSTMS
2.56 11.78
STMS 2.42 10.67
Neutrophils were pre-incubated with indicated solutions for twenty minutes before 
addition of cytochalasin B (l|ag/ml) and fMLP (10“^ M. The supernatants were aspirated 
and used for degranulation assays. The cell pellets were re-suspended in FIO and 
assayed for alkaline phosphatase as described in materials and methods. The 
supernatants were assayed for plasminogen activator as described in materials and 
methods. The remainder of the supernatants were used for elastase / MPO and 
collagenase assays. All of these other assays produced results indicating an inhibition 
of release of enzymes.
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3.7.6. Release of Alkaline Phosphatase
Alkaline phosphatase is an integral membrane protein found in the membranes of 
secretory vesicles, and as such can be used as a marker for release of vesicle contents.
This is a highly specific assay, but also an exceptionally tedious one, with numerous 
stages. As the stimulation of the cells is stopped in a manner unlike the others (addition 
of three volumes ice cold buffer) this makes the assay incompatible with other 
degranulation assays. Also the numerous incubation steps, and volumes used prevent 
any other experiments being carried out concomitantly with this one. It does have the 
advantage, however, of being the easiest assay to quantitate. The amount of alkaline 
phosphatase present can be calculated from the extinction co-efficient for pNPP of 18.6 
per mM per cm path length. As can be seen from fig. 33, there were no detectable 
differences between the treatments used.
4
3 .7 .7 .  Cell viability / secretory vesicles
The release of lactate dehydrogenase (LDH) has been used as a standard marker of non- 
apoptotic cell death. This enzyme was investigated for two reasons. The first was to see 
whether release of STMS from monocytes was due to cell lysis rather than secretion.
The hypothesis being that steroids might promote lysis of monocytes in culture. The
■V.levels of LDH found in STMS was consistently higher than that found in CMS (about 
15%), showing that dexamethasone treatment did induce a higher level of cell lysis than 
the control. The contaminating levels of LDH was removed from STMS during the first 
two stages of purification (fig. 3 strategy X).
Treatment of PMNs with purified STMS consistently decreased the levels of LDH in 
the supernatant released in response to fMLP. In fact STMS treatment gave less release 
of LDH than the negative controls. Fig. 34 shows a typical result for such an assay.
Results
Fig. 34 Release of LDH from neutrophils treated with STMS.
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Neutrophils were pre-treated with increasing concentrations of STMS, before 
stimulation with cytochalasin B (Ipg / ml) and fMLP (lO'^M). Supernatant was 
assayed for the presence of LDH as described in materials and methods.
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3.7.8. Phagocytosis of Latex Beads
In view of the inhibition of the release of primary granules by STMS it was anticipated 
that STMS would also inhibit phagocytosis. This was assayed using the latex bead 
assay (Wojiak & Crossan, 1993) and the results were consistently negative (not 
shown).
3.8.1. Metabolic Burst
Of all the aspects of PMN function assayed, the analysis of the metabolic burst is the 
least technically challenging to perform, and as a result is the most extensively studied.
The activation is by translocation of the regulatory subunits to the cytosolic surface of 
vesicle membranes or the PM. The process is activated by fMLP mediated by PKC and 
therefore PMA is an efficient agonist, and the agonist of choice in the assays, because 
the response is delayed and prolonged. Investigation of the effect of STMS on the 
PMA-stimulated respiratory burst was carried out at all stages of the purification (fig.
35). Starting material inhibited in a dose-dependent fashion (fig. 36), and this effect co­
purified with the stimulation of the dispersive locomotion until the reverse phase step 
(fig. 37). After reverse phase, however highly purified STMS failed to retain the ability 
to inhibit the respiratory burst. The fractions containing the inhibitory activity have not 
yet been identified. This work was repeated using cytochalasin B primed PMN and 
fMLP as the stimulant. Because responses to these agents are much faster than to PMA, 
the results are less accurate, but the conclusion that pure STMS was inactive in this 
assay was verified.
3.8.2. Metabolic Burst Induced by Latex Beads
■;S-
Phagocytosis of particles is an alternative (closely physlogical) method for initiating the 
metabolic burst of neutrophils. It was of interest to determine whether or not STMS had
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any effect on the phagocytosis induced metabolic burst. Latex beads at a final dilution 
of 100,000 were added as a stimulus to each tube, and the response was measured 
using the program described above. It was very clear that the response induced by
:beads differed from that induced by fMLP in several respects. It was much slower in 
onset and the peak response was much lower; however to compensate, it continued for
a much longer time so that the net release of active oxygen species was in excess of that 
induced by fMLP (fig. 38a). If cytochalasin B is added to the cells immediately before 
the beads, then there is a small response, but this very quickly returns to baseline.
However, if the cytochalasin is added one minute earlier, then there is no initial 
response by the cells when the beads are added (fig. 38a). Studies of the effect of 
STMS were carried out with material purified by protocol Y in which the major initial 
step is vacuum dialysis. Here the dialysate contains all of the small molecular 
components whilst the dialysand contains the small molecular components at their 
original concentration but is greatly enriched in the high MW components. I
■!
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Fig. 35 Response of neutrophils incubated in different purities of STMS to fMLP 
stimulation as visualised by chemiluminescence
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Neutrophils were incubated in dilutions of STMS for twenty minutes before stimulation 
with fMLP (10‘^M final concentration). The cells were primed with cytochalasin B 
(IfXg/ml) immediately before addition of the stimulant. Dialysed STMS was diluted 
with HS to approximately the equivalent starting volume before addition to PMNs.
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Fig 36 Inhibition of chemiliuminescence of neutrophils to STMS showing dose response
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Neutrophils were incubated at 37®C for 30 minutes in the presence of increasing doses 
of crude STMS, 200pl, 500|Ll1 and 700|iL The cells were stimulated with cytochalasin 
B (l|lg/ml) and fMLP (10"^M).
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Fig. 37 Inhibition of chemiluminescence of neutrophils incubated in the presence of 
partially purified STMS.
Neutrophils were pre-incubated with dilutions of ppSTMS for twenty minutes before 
stimulation with PMA (1 |lg/ml).
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If the STMS is added to the ceils immediately before the beads, then there is a marked 
decrease in the overall quantity of O2" produced, (fig 38b) Here 400 jll or 200|ll of 
STMS that had passed through dialysis membrane (apparent cut-off lOkD) inhibited the 
production of O2" by 44% and 19% respectively. These amounts of STMS correspond 
to 44% and 22% of the total volume of the tube, and so it is possible that the effect may 
be due to a scavenging effect by the factor. To check if this is the case, it was decided 
to incubate the cells in the presence of the factor for 30 minutes prior to the addition of 
luminol and beads. In this case, 400jil and 200^1 of STMS (again the dialysate) 
inhibited the response by 42% and 53% respectively (fig 38c). This must then exclude 
the STMS inhibition of latex beads induced metabolic burst from being a purely 
scavenging effect, but does tie in with the results of sections 3.8.2. The inference from 
these results is that the factor which inhibits the latex bead induced metabolic burst is 
not the same as the factor which induces dispersive locomotion.
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Fig. 38 Inhibition of latex bead induced chemiluminescence of neutrophils by 
STMS
Treatment Arbitrary Units Percentage of Positive Control
Cytochalasin B + fMLP 58, 571 100
Cytochalasin B + Beads 0 0
Beads 94, 802 162
Fig. 38b
Fig. 38c
Treatment Arbitrary Units Percentage of Positive Control
Positive Control 59, 913 100
200|al Dialysate 48, 655 81
400f1 Dialysate 33, 322 56
Treatment Arbitrary Units Percentage of Positive Control
Positive Control 44, 399 100
200|ll Dialysate 20, 799 47
400|il Dialysate 16, 828 38
Neutrophils were incubated in the appropriate treatment for twenty minutes before 
stimulation with either fMLP (fig. 38a only) or with latex beads. The areas under the 
graphs, indicating the total luminescence produced) were calculated automatically by the 
computer and tabulated as above.
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Summarised Table of Results
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4 .1 . Overview
Despite the intensive work on this factor the active component of STMS has not yet 
been identified and until this is achieved, questions will remain. The most important 
being is the activity due to a single molecule or a combination of events and 
circumstances. Secondary questions concern its role as a possible anti-inflammatory
supernatant, but if diluted 10 fold the activity is too weak to detect.
2) When the complex is dissociated, the activity is entirely associated with the low 
molecular weight component, and the activity is increased dramatically. However the
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agent and mediator of steroid action. Little is currently known about the biogenesis of 
the molecule. There are several possible hypotheses:
1 synthesis and secretion in response to a steroid signal,
2 release of a cytosolic component due to steroid induced cell lysis,
3 proteolysis of a released protein/peptide, or failure of complete proteolyis
resulting in an aitefact.
Of these only the first possibility suggests that the factor could be a physiological 
mediator of steroid action. The initial work of Stevenson backed up to some extent by 
Chettibi indicated that the generation of STMS in response to dexamethasone was 
blocked by protein synthesis inhibitors. If this was substantiated, then STMS could 
well be the product of a steroid up-regulated gene. The molecular nature of STMS is 
again uncertain. Incubation with proteases has been used to abolish the activity, 
although in the light of the unusual dose response curve these experiments would 
require to be done with great precision. Information that has arisen during the 
purification procedure suggests the following;
1) STMS is produced as a high molecular weight complex which is dissociated only at 
extremely high salt concentration or very low pH and is therefore held together by ionic 
interactions. In this form it is highly active at the concentration found in the cell
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activity is auto-inhibitory. It has a concentration optimum corresponding to a 1000 fold 
dilution of the starting material. However, at higher concentrations it is without 
apparent effect on the cells.
While the present work was being carried out, these features were being elucidated, and 
they impinge on the present results of the study. In terms of its biological action the 
production of dispersive locomotion is not unique, but the fact that it gives dispersive 
locomotion in a uniform concentration is apparently unprecedented. Despite these 
unusual features, it had to be borne in mind that STMS could be an already 
characterised molecule with another range of activities in addition to those described 
here.
For these two models of PMN locomotion, there would require to be either a gross 
movement of polymerised actin along the length of the PMN, or else there has to be a 
rapid polymerisation / depolymerisation of microfilaments at opposite poles of the 
migrating PMN. This would involve a number of actin sequestering proteins to interact
4 .2 .  Dispersive locomotion induced by STMS
The initial thrust of this investigation was to find out how dispersive locomotion 
worked. The problem is that dispersive locomotion requires either inertia or polarisation 
of the locomotory machinery. Inertia can be ruled out on two grounds: firstly low 
Reynold's number hydrodynamics applies to objects of cellular size and inertia is not 
possible. The second is that the cells quite clearly stop between 'steps'. Thus the 
problem of persistence must be due to polarisation of the motor itself. We therefore 
required to know how the cells move. Visual observation suggests that the motion is 
either looping or somersaulting. This point could be resolved by the use of side-view 
microscopy (G. Dunn, personal communication), but this has not yet been undertaken 
and so therefore the conclusions have to be indirect. In this respect the morphology of 
polymerised actin in STMS treated PMNs provides the main source of information.
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Fig. 39. Schematic Representation of Neutrophil Locomotion.
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and to release their sequestered G-actin simultaneously in response to localised cues. 
One such cue could be a highly localised calcium concentration change as described by 
Berridge (1997).
Video footage (not shown) of PMNs migrating across a flat BSA coated glass surface 
shows a slow steady stretching of the leading edge of the cell, pulling the cell body 
until the cell body detaches from the substrate propelling the body forward. It is 
normally immediately after this recovery of a degree of roundness that any changes in 
direction of motility occur. The exception to this change in direction was when the tilted 
stage tracking assays were performed. Here the STMS treated PMNs migrated 
downhill, and perhaps these would make fascinating viewing with the Dunn side-view 
microscope.
Visual observations are similar to the looping model proposed for locomotion of STMS 
treated cells, but bears no resemblance to the somersaulting model with its continuous 
reversals of polarity. However, STMS-treated PMN appear to have a broader 
polymerised actin-poor pole and a narrow polymerised actin-rich pole (Fig. 24). Again 
by analogy the narrow end would be taken as the tail. Our observations are consistent 
with the narrow end being the adhesive (adhered) end whilst the broad end would be 
the exploring (head) end. This model requires a transient switch of role such that the
7
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head becomes adhesive, followed by breakage of tail adhesion and retraction of the 
body. At this point the tail forms a strong adhesion to the substrate and the head loses 
its adhesiveness. This might require translocation of actin within the cell or else it could 
largely involve local perturbation of the equilibrium between polymerised and 
unpolymerised actin.
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In order to bring about persistent locomotion this model requires that the adhesion site 
made by the tail is polarised and tends to act as a hinge giving a preferred direction to 
the apparently flexible cell body. Such polarity could easily be provided by parallel 
actin bundles.
It has been mentioned earlier that colchicine induces motility that has been similarly 
described to STMS (Stevenson's original assays showing the migration of cells away 
from a cell pellet), and it has been documented that colchicine reduces adhesion of 
PMN (Lackie, 1974). It is therefore possible that STMS mediates it's dispersive effects 
in a similar manner to colchicine, i.e. by reducing adhesion and so allowing rolling of 
the cells. Rolling, however, does not adequately describe the motility observed when 
adherent PMN are stimulated with STMS.
4 .2 .2 .  Does STMS have receptors?
For some agonists the receptors have not been identified. (This is currently the case 
with lipocortin 1.) In the case of STMS, the signalling system has the property that at 
high or low dose levels there is virtually no response, whilst there is an optimum 
response over a range of concentration of fold. Such optimum responses are
well known. fMLP, for example, gives a peak locomotory response at about lO'^M, 
however there is a big difference between this and STMS because fMLP has a spectrum 
of high dose responses that do not include locomotion. For a ligand to have no action 
whatsoever at high concentration, there are very few mechanistic possibilities. Of these 
the major one is that the ligand signals by cross-linking the receptor. At low receptor
Discussion
occupation, cross-linking is an efficient process, but at high receptor occupation cross 
linking becomes less and less probable (auto competitive inhibition). This mechanism 
has one special requirement, that the ligand is bidentate. One molecule that has 
appropriate characteristics is lipocortin 1, which has a fourfold repeat of a calcium 
binding/ lipid binding motif.
4 .3 .  Adhesion
Neutrophil adhesion is well understood in terms of the selectins and the integrin/ cam 
molecules. However, these adhesive mechanisms do not necessarily apply to the 
behaviour on BSA coated glass. One of the interesting and perhaps relevant 
observations concerning selectin-based adhesion is that the active selectins / integrins 
are clustered on to microvilli (Pavalko et al, 1995; Erlandsen et al., 1993)) and that 
dispersed selectin / integrin is relatively ineffective in the adhesion process (Lorant et 
al., 1995). This mechanism for reduced adhesion fits nicely with the observations of 
the smoothness of the STMS treated PMN membrane. The smoothness was described 
by Dr. A. Ridley as 'quite remarkable' when presented to her on a visit to the 
laboratory, however, she could cast no light on to the possible signalling pathways 
likely to lead to such a phenomenon. The need for clusters of integrins might well apply 
to all adhesion molecules, including the unknown molecules that interact with protein- 
coated glass. Nevertheless because the number of surface adhesion molecules is not 
altered by this mechanism there may be a distinction to be made between static and 
dynamic adhesion (Ackerman et al., 1993; Lorant et al., 1995). Thus a moving cell 
may only be able to make an adhesive contact if it has a compact cluster of adhesion 
molecules exposed on a projection. However once it makes extensive contact with 
another surface this mechanism should be unimportant. Thus the dynamic adhesiveness 
of a smooth cell could be low whilst its static adhesiveness could be normal. This 
argument could be taken further to suggest that clustered adhesion molecules act 
cooperatively as a strong adhesion site, but isolated adhesion molecules, whilst
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contributing equally to the overall adhesion energy, nevertheless make contacts that are 
easily broken. This suggests a basis for the results observed in the tilt assay.
-1:
4 .3 .1 .  STMS mediated adhesion
It was noted during the tilted tracking assays that STMS does not actually cause many 
cells to detach from the BSA coated glass, but instead acts in a more subtle manner.
The motion of the neutrophils was observed to resemble that of the cells on a horizontal 
surface with the sole difference that they all moved in roughly the same direction. From 
the appearance it is highly unlikely that the cells were rolling or even sliding down the 
slope. This suggests that the cells were still attached to BSA coated glass, at a single
attachment point and that the driving force for locomotion was still largely the intrinsic
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motor activity of the cell. Considering the effect of persistence on perceived cell speed, 
if the step time is much less than the frame-sampling time then the instantaneous speed 
measurement will be a gross underestimate. As the frame sampling time falls below the 
step-time, then the measured instantaneous speed will asymptote to its true value. 
Tilting the surface polarised all of the steps down the slope, and so the instantaneous 
speed of the cells was then measured coixectly regardless of frame time. Thus on the tilt 
assay an increase in speed would be expected if the frame time was much greater than 
the persistence time. Because we measure a persistence of about 30 seconds with a 
frame time of 5 seconds, any increase in the measured speed in the tilt assay can only 
be due to a very small extent to the increased persistence. In the present case the speed 
is approximately doubled and this means that the locomotory process itself must be 
faster. One model for this might be that the trigger for locomotion is extension of the 
cell beyond a critical length; when this happens the cycle of formation of a head/ 
substrate adhesion begins. If this were the trigger for locomotion then tethered down 
slope locomotion would occur at a faster rate than locomotion on the flat.
i
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4 .3 .2 .  Adhesion mediated by other factors
Treatment with other agonists such as fMLP and CMS not only did not induce the 
PMN to migrate exclusively downhill, and PMNs appeared to be unaffected by the 
application of a lateral gravitational force on the plane of migration. This could be 
primarily due to the PMNs treated with fMLP or CMS not having a loosely adherent 
head, and a more tightly adherent tail, but instead being more uniform in the locations 
of adhesions. This coupled with a more rounded cell shape would prevent these cells 
from setting up a gravitationally induced polarity, and so their migration would 
continue to be non-dispersive. Thus PMNs treated with an agent that does not induce 
this highly specific form of bipolarity (without decreasing adhesion) would be unlikely 
to migrate down the slope. IL-8 has been shown to produce a bipolar morphology 
which bears a superficial resemblance to that induced by STMS, but this would not be 
expected to produce a dispersive motility down slope because there is an increase in cell 
adhesion. Perhaps the presence of IL-8 in the starting material is in part responsible for
4the adhesive properties of crade STMS, and its removal during purification allows the 
true nature of STMS effects on adhesion to be elucidated.
It is possible that the loss of adhesion observed with ppSTMS treatments may be in part 
or wholly due to the unusual morphology of motile neutrophils in an STMS 
environment. With only a small part of the cell suspected to be in contact with the 
substratum (endothelial cells or protein coated glass) then when the cells were washed, 
several cells could be washed away.
4 .3 .3 .  Persistent motility is not due to locking of rho activation state 
It has been noted that the induced dispersive motility by STMS caused an increase in '1the persistence of migration, and so although the cell is dynamic, and moves at high 
speed, the overall conformation of the cell did not alter significantly. This was in 
contrast to work by Ehrengruber et al. (1995) who showed that by blocking activity of 
the small G-protein rho by ADP-ribosylation, the rate of change of PMN shape was
"A
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increased. This locking of the activation state of the G-protein led to very small 
persistence (Takaishi et al., 1993) as shown by the clearing of gold particles from areas 
of migration (phagokinesis).
4.4. Degranulation
'3
All of the degranulation and respiratory burst assays were performed with neutrophils 
in suspension, and so all of the results will be skewed towards lower values, especially
the positive controls. Nathan (1987) showed that these responses were increased in 
magnitude and duration by using adherent neutrophils. Lack of sensitivity of the assay 
prevented this from being a suitable assay in my experiments. The results from the 
adhesion experiments would also have made the results from these assays open to 
question, especially any correction of the results for the number of cells likely to be 
present in the assay. The reduced degranulation response is conducive with the 
possibility of reduced MT content. Were there to be a reduced microtubule content, then 
it may be expected that degranulation may be inhibitable. As shown in 3.7.2-3.7.4, 
STMS in its partially purified state inhibits the release of primary granules and secretory 
vesicles, along with the respiratory / metabolic burst (3.8.). These effects may be due 
to inhibition of the motility of microtubules, but it is also possible (especially in the case 
of the respiratory burst) that the re-organisation of the microfilament network may have 
a direct bearing on the effects observed. Rossi (1986) summarised findings that 
microfilaments are required to move several components of the oxidase to the cell 
surface allowing activation. If the majority of microfilaments are sequestered to one end 
of a polymerised cell, then it is conceivable that the reduction in metabolic burst is due 
to the microfilaments not being capable of mobilising these components. That there is 
an increase in the level of metabolic burst in response to fMLP if the cells have been 
pre-treated with cytochalasin B, may indicate that a disruption of microfilaments is 
necessary for optimum respiratory burst activity, or for easier assembly of the oxidase 
components. However, if STMS were to make this disruption almost complete, or 
were to induce sequestering of F-actin to a localised area, then the oxidase could not be
125
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assembled effectively. The apparent discrepancy arises when the differences between 
complete microfilament collapse and peripheral microfilaments are ignored. If 
cytochalasin D is used at low concentrations and for only a very short period of time, 
then only the peripheral microfilaments are apparently effected. STMS appears to effect 
all the microfilaments in neutrophils, and yet have no effect on endothelial cells at 
concentrations used to treat PMNs (not shown). It should though be noted that the 
addition of a concentration of cytochalasin B that increases fMLP induced metabolic 
burst, inhibits the metabolic burst induced by beads (3.8.2). STMS that has passed 
through dialysis tubing inhibits the response in a manner suggesting initially a 
scavenging role. However, in line with the inhibition of azurophil granule release this 
suggestion was reduced by the effect being increased dramatically by pre-incubating the 
cells with STMS. The increase in inhibition by a factor of 1.5 fold must be due to a 
signalling event taking place inside the cells.
4 .4 .1 .  Inhibition of primary granule release
The amount of elastase released from PMNs treated with STMS was of the order of 
2500ng/ml supernatant. This compared with 4600ng/ml with the fMLP control 
(approximately 10  ^ cells per ml). These values were consistently obtained with 
ppSTMS, although as has been noted earlier, different purifications and different 
methods of purification gave different activities. [These elastase levels are in equivalent 
units as calibration assays were performed with porcine pancreatic elastase (ICN 
Flow).]
The inhibition of late granules (azurophil) is a notably unusual effect for an anti­
inflammatory drug. As noted above, many such diugs knock out the cyclooxygenase / 
lipoxygenase systems. Others, such as Tenidap (Blackburn et al, 1991) may interfere 
with the activation of key enzymes, such as myeloperoxidase. This enzyme, as well as 
having effects on the metabolic burst pathway is also required for the full activation of 
collagenase. With both of these pathways being inhibited, probably to a high degree.
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127
then the neutrophil will have great difficulty in responding in an inflammatory manner. 
In much the same way therefore STMS should be a potent anti-inflammatory agent, 
even without any of the other effects. There is a possible precedent for the type of 
activity observed with STMS, in that there is inactivation of azurophil granule product 
release (Blackburn et al., 1991) and as a result there is inactivation of collagenase. 
Blackburn claims that Tenidap inhibits collagenase activity, and yet surely the real effect 
is in the inactivation of MPO release. My results show that there is also inactivation of 
NADPH oxidase even in response to PMA challenge.
4 . 4 . 2 .  Effects of STMS on secondary granule release
It should be noted that there was no noticeable changes in the levels of the fragments of 
collagen at 20-30kD as suggested by Bode et al. (1994). This may be because the gel 
front was generally allowed to run off the end of the gel to allow differentiation 
between the larger fragments and the a  and p fragments (Sorsa et al., 1985). 
Johansson et al. have recently (1997) discussed the possibility that neutrophils use 
MPO for adhesive purposes. If neutrophils are inhibited from releasing MPO, this 
could decrease their ability to adhere to a substrate. This could explain the anti-adhesive 
function of STMS reported by Chettibi et al. (1993) using protein coated glass, but the 
loss of adhesion to cytokine activated endothelium is more likely to involve an 
inhibition of integrin / selectin function / recognition on the neutrophils.
4 . 5 .  The anti-inflammatory role of STMS
As STMS-like activity has only been shown to be derived from monocytes grown in 
culture (or recently removed from a spleen) then there is a possibility that STMS may 
have an anti-inflammatory role in the serum. This would therefore imply that the anti­
inflammatory effect most likely to be noticed would be as an anti-adhesive. However, 
with the concomitant release of IL-8, it is not likely that STMS would have much of an 
effect, except in the reduction of fMLP-induced adhesion, which is after all, the 
agonist-induced adhesion that PMN respond to most quickly. Were STMS to be used
:S
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clinically, then it would of course be free from IL-8 and other contaminants, such as the 
molecule that inhibits the metabolic burst. Therefore the pure STMS as a drug would 
primarily act in an anti-adhesive capacity in the blood stream acting on the earliest of 
stages i.e.. the interaction between the PMN and the endothelium. Any PMN that 
manage to adhere and extravasate could be anticipated to be incapacitated by incubation 
in STMS for a prolonged period, and as a result be incapable of releasing the majority 
of the lytic enzymes (primarily in the azurophil granules). That inflammatory events 
such as the release of secondary vesicles and the activation of the respiratoiy burst are 
not totally inhibited by STMS would be of lessened concern as the PMNs would not be 
capable of causing any serious damage due to the inactivation of the release of MPO 
and therefore knocking out the collagenase damage and to a lesser extent damage 
caused by HOCl and its metabolites.
I have shown that the machinery to engulf beads or bacteria is not effected by 
incubation with STMS. But, with the release of myeloperoxidase effectively 'knocked- 
out' by this treatment, then killing of the bacteria may be reduced somewhat. This, of 
course, relies on there being incomplete internal degranulation, which may involve a 
different pathway from degranulation to the surface induced by soluble stimuli. Ideally 
experiments should be performed with opsonised particles to determine if the release of 
primary vesicles can be inhibited to these stimuli as well as with soluble stimuli.
' I
4 . 6 .  What is STMS?
As has been stated above, STMS could be a fragment of another molecule, such as 
Lipocortin I, or be a small protein / peptide such as Thymosin (34. Indeed, because of 
the uncertainty over the size of STMS, it could be Lipocortin I. If STMS is a fragment 
of a larger protein, then there are two possibilities for its existence. The first is that it is 
an artefact produced almost at random with no real physiological role, as the crade 
supernatant is not in itself anti-inflammatory (as shown by increasing basal levels of 
adhesion and stimulating the release of granules). The second possibility is that STMS
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is a specific cleavage product which is produced on demand by the monocytes and as 
such would have specific anti-inflammatory effects. It would seem more than 
coincidence that the only cell types that produce STMS-like activity are monocytes and 
macrophages, only produce it in response to corticosteroids and are the only cell types 
that would be in both the blood stream and sites of inflammation where production of 
such a factor would be beneficial.
If STMS is a product of a larger anti-inflammatory molecule, such as lipocortin I, then 
there is evidence that smaller fragments of lipocortin can produce anti-inflammatory 
effects (Lloret & Moreno, 1994), although the effectiveness of these has been disputed 
by other investigators (van Binsbergen et al, 1989).
129
If, as very recent work may indicate, STMS is oxidised Thymosin p4 (J. Young, 
personal communication), then it is possible that the decrease in elastase activity may be 
due to leukocyte elastase inhibitor, a factor that co-purifies with Thymosin p4 (Dubin et 
al, 1992). However, as MPO is also inhibited to a similar degree, it is unlikely that the 
decrease in measurable activity of primary vesicle contents would be caused by this 
factor. Also, this factor has sequence homology to plasminogen activator inhibitors, 
and as I have found no evidence of such inhibitory behaviour from ppSTMS then it is 
concluded that this leukocyte elastase inhibitor is unlikely to be responsible for the 
inhibition of primary granule release. Instead it is therefore probable that the inhibition 
is due to STMS.
4 . 7 .  Assays with ppSTMS
Partially purified factors are very difficult to quantitate, and concentrations are likely to 
change from purification to purification. With this in mind, the concentrations were 
calculated from the size of the fraction peak. As this often had a distinct shoulder, then 
the absolute concentration was impossible to determine, although the final concentration 
would be of the order of nanograms per ml. As has been stated above, the methodology
Discussion
of purification was in a state of evolution during these assays, and therefore it follows 
that the concentrations and purity of samples produced were highly changeable. Most 
of the individual groups of experiments were performed with one particular sample, 
and whereas the results from assay to assay would not be expected to vary, the results 
between experiments would. This is especially true of tracking assays which vary on a 
daily basis.
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Further work
Utilising the latest purifications of STMS, all of the above assays should be repeated, 
paying particular attention to the oxidation state of the factor. That oxidation of 
methionine residues can alter the ability of a peptide to affect PMN behaviour is not a 
new phenomenon, and so it was not entirely unexpected that the factor was present in 
isoforms indistinguishable by gel filtration or Mono-Q chromatography. Indeed, the 
two fractions are sufficiently close on reverse phase HPLC that they often appear 
together. Also, the non-oxidised form of the factor does not produce dispersive 
locomotion, and may even inhibit the oxidised form from being as effective.
Recently, Lawrence and co-workers have developed a conductimetric assay system that 
is sufficiently sensitive to assay many of the enzymes released by PMN when 
Stimulated. The only requirement for this assay is that either the natural substrate 
produces a change in the ionic strength of the solution, or a synthetic analogue can be 
produced to be specific for the enzyme. This method would allow very rapid analysis 
of data, and with each chamber being independent of the others, it is possible that 
measurements could be made at very short time intervals, and so give the kind of time 
course information lacking from these results.
It would also be of interest to investigate the morphological studies in greater detail, ;:3"3
including the use of fluorescent latex beads for phagocytosis assays. These beads 
would have the advantage in that they could be visualised in living tissue, and so the 
effects of STMS could be observed in real time on the phagocytosis of particles.
To continue the morphological assays using electron microscopy would be 
advantageous in determining vesicle transport within the cell. With the release of 
primary granules being inhibitable with STMS, and with abundant supplies of the
I'
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factor available to perform such assays, it would be of interest to determine if these 
vesicles are sequestered within the STMS treated PMNs.
The factor now appears to be an oxidised derivative of Thymosin p4, one of the major 
actin sequestering proteins in PMNs, and as this can be easily purified from other cell 
types, then the number of assays is almost limitless. It would be ideal to perform a 
series of toxicological screens on the factor (unlikely to be toxic at the levels required 
for dispersive motility) and perhaps even animal models of inflammation; oedema 
formation being an obvious experiment to attempt (bearing in mind the differences in 
inhibition of lipocortin I with different stimuli).
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